메뉴 건너뛰기




Volumn 41, Issue 12, 2013, Pages 1975-1993

A perspective on the prediction of drug pharmacokinetics and disposition in drug research and development

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; CARRIER PROTEIN; CYTOCHROME P450; DRUG METABOLIZING ENZYME; IRBESARTAN; MIDAZOLAM; NEW DRUG; PRAVASTATIN; REAGENT; REPAGLINIDE; ROSUVASTATIN; SIMVASTATIN; XENOBIOTIC AGENT;

EID: 84888632710     PISSN: 00909556     EISSN: 1521009X     Source Type: Journal    
DOI: 10.1124/dmd.113.054031     Document Type: Article
Times cited : (84)

References (227)
  • 1
    • 53849092394 scopus 로고    scopus 로고
    • In vitro biliary clearance of angiotensin II receptor blockers and 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors in sandwich-cultured rat hepatocytes: Comparison with in vivo biliary clearance
    • Abe K, Bridges AS, Yue W, and Brouwer KL (2008) In vitro biliary clearance of angiotensin II receptor blockers and 3-hydroxy-3-methylglutaryl- coenzyme A reductase inhibitors in sandwich-cultured rat hepatocytes: comparison with in vivo biliary clearance. J Pharmacol Exp Ther 326:983-990.
    • (2008) J Pharmacol Exp Ther , vol.326 , pp. 983-990
    • Abe, K.1    Bridges, A.S.2    Yue, W.3    Brouwer, K.L.4
  • 2
    • 0035478779 scopus 로고    scopus 로고
    • Predicting the impact of physiological and biochemical processes on oral drug bioavailability
    • Agoram B, Woltosz WS, and Bolger MB (2001) Predicting the impact of physiological and biochemical processes on oral drug bioavailability. Adv Drug Deliv Rev 50 (Suppl 1):S41-S67.
    • (2001) Adv Drug Deliv Rev , vol.50 , Issue.SUPPL. 1
    • Agoram, B.1    Woltosz, W.S.2    Bolger, M.B.3
  • 3
    • 84865003528 scopus 로고    scopus 로고
    • A quantitative approach to hepatic clearance prediction of metabolism by aldehyde oxidase using custom pooled hepatocytes
    • Akabane T, Gerst N, Masters JN, and Tamura K (2012) A quantitative approach to hepatic clearance prediction of metabolism by aldehyde oxidase using custom pooled hepatocytes. Xenobiotica 42:863-871.
    • (2012) Xenobiotica , vol.42 , pp. 863-871
    • Akabane, T.1    Gerst, N.2    Masters, J.N.3    Tamura, K.4
  • 4
    • 68349150527 scopus 로고    scopus 로고
    • Towards a quantitative framework for the prediction of DDIs arising from cytochrome P450 induction
    • Almond LM, Yang J, Jamei M, Tucker GT, and Rostami-Hodjegan A (2009) Towards a quantitative framework for the prediction of DDIs arising from cytochrome P450 induction. Curr Drug Metab 10:420-432.
    • (2009) Curr Drug Metab , vol.10 , pp. 420-432
    • Almond, L.M.1    Yang, J.2    Jamei, M.3    Tucker, G.T.4    Rostami-Hodjegan, A.5
  • 5
    • 34548040152 scopus 로고    scopus 로고
    • High throughput solubility measurement in drug discovery and development
    • Alsenz J and Kansy M (2007) High throughput solubility measurement in drug discovery and development. Adv Drug Deliv Rev 59:546-567.
    • (2007) Adv Drug Deliv Rev , vol.59 , pp. 546-567
    • Alsenz, J.1    Kansy, M.2
  • 6
    • 34247552300 scopus 로고    scopus 로고
    • Development of a partially automated solubility screening (PASS) assay for early drug development
    • Alsenz J, Meister E, and Haenel E (2007) Development of a partially automated solubility screening (PASS) assay for early drug development. J Pharm Sci 96:1748-1762.
    • (2007) J Pharm Sci , vol.96 , pp. 1748-1762
    • Alsenz, J.1    Meister, E.2    Haenel, E.3
  • 7
    • 0028948839 scopus 로고
    • A theoretical basis for a biopharmaceutic drug classification: The correlation of in vitro drug product dissolution and in vivo bioavailability
    • Amidon GL, Lennernäs H, Shah VP, and Crison JR (1995) A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res 12:413-420.
    • (1995) Pharm Res , vol.12 , pp. 413-420
    • Amidon, G.L.1    Lennernäs, H.2    Shah, V.P.3    Crison, J.R.4
  • 8
    • 0025311288 scopus 로고
    • Epithelial transport of drugs in cell culture. I: A model for studying the passive diffusion of drugs over intestinal absorptive (Caco-2) cells
    • Artursson P (1990) Epithelial transport of drugs in cell culture. I: A model for studying the passive diffusion of drugs over intestinal absorptive (Caco-2) cells. J Pharm Sci 79:476-482.
    • (1990) J Pharm Sci , vol.79 , pp. 476-482
    • Artursson, P.1
  • 9
    • 0025804183 scopus 로고
    • Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells
    • Artursson P and Karlsson J (1991) Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. Biochem Biophys Res Commun 175:880-885.
    • (1991) Biochem Biophys Res Commun , vol.175 , pp. 880-885
    • Artursson, P.1    Karlsson, J.2
  • 10
    • 0025329248 scopus 로고
    • Epithelial transport of drugs in cell culture. II: Effect of extracellular calcium concentration on the paracellular transport of drugs of different lipophilicities across monolayers of intestinal epithelial (Caco-2) cells
    • Artursson P and Magnusson C (1990) Epithelial transport of drugs in cell culture. II: Effect of extracellular calcium concentration on the paracellular transport of drugs of different lipophilicities across monolayers of intestinal epithelial (Caco-2) cells. J Pharm Sci 79:595-600.
    • (1990) J Pharm Sci , vol.79 , pp. 595-600
    • Artursson, P.1    Magnusson, C.2
  • 11
    • 0036891948 scopus 로고    scopus 로고
    • The influence of non-specific microsomal binding on apparent intrinsic clearance, and its prediction from physicochemical properties
    • Austin RP, Barton P, Cockroft SL, Wenlock MC, and Riley RJ (2002) The influence of non-specific microsomal binding on apparent intrinsic clearance, and its prediction from physicochemical properties. Drug Metab Dispos 30:1497-1503.
    • (2002) Drug Metab Dispos , vol.30 , pp. 1497-1503
    • Austin, R.P.1    Barton, P.2    Cockroft, S.L.3    Wenlock, M.C.4    Riley, R.J.5
  • 13
    • 14144250264 scopus 로고    scopus 로고
    • Caco-2 permeability of weakly basic drugs predicted with the double-sink PAMPA pKa(flux) method
    • Avdeef A, Artursson P, Neuhoff S, Lazorova L, Gråsjö J, and Tavelin S (2005) Caco-2 permeability of weakly basic drugs predicted with the double-sink PAMPA pKa(flux) method. Eur J Pharm Sci 24:333-349.
    • (2005) Eur J Pharm Sci , vol.24 , pp. 333-349
    • Avdeef, A.1    Artursson, P.2    Neuhoff, S.3    Lazorova, L.4    Gråsjö, J.5    Tavelin, S.6
  • 14
    • 33845996187 scopus 로고    scopus 로고
    • Scaling factors for the extrapolation of in vivo metabolic drug clearance from in vitro data: Reaching a consensus on values of human microsomal protein and hepatocellularity per gram of liver
    • Barter ZE, Bayliss MK, Beaune PH, Boobis AR, Carlile DJ, Edwards RJ, Houston JB, Lake BG, Lipscomb JC, and Pelkonen OR, et al. (2007) Scaling factors for the extrapolation of in vivo metabolic drug clearance from in vitro data: reaching a consensus on values of human microsomal protein and hepatocellularity per gram of liver. Curr Drug Metab 8:33-45.
    • (2007) Curr Drug Metab , vol.8 , pp. 33-45
    • Barter, Z.E.1    Bayliss, M.K.2    Beaune, P.H.3    Boobis, A.R.4    Carlile, D.J.5    Edwards, R.J.6    Houston, J.B.7    Lake, B.G.8    Lipscomb, J.C.9    Pelkonen, O.R.10
  • 15
    • 84888592045 scopus 로고    scopus 로고
    • Differences in cytochrome P450-mediated pharmacokinetics between Chinese and Caucasian populations predicted by mechanistic physiologically based pharmacokinetic modelling
    • DOI: [published ahead of print]
    • Barter ZE, Tucker GT, and Rowland-Yeo K (2013) Differences in cytochrome P450-mediated pharmacokinetics between Chinese and Caucasian populations predicted by mechanistic physiologically based pharmacokinetic modelling. Clin Pharmacokinet DOI: [published ahead of print].
    • (2013) Clin Pharmacokinet
    • Barter, Z.E.1    Tucker, G.T.2    Rowland-Yeo, K.3
  • 17
    • 58449123081 scopus 로고    scopus 로고
    • Does human pharmacokinetic prediction add significant value to compound selection in drug discovery research?
    • Beaumont K and Smith DA (2009) Does human pharmacokinetic prediction add significant value to compound selection in drug discovery research? Curr Opin Drug Disc Dev 12:61-71.
    • (2009) Curr Opin Drug Disc Dev , vol.12 , pp. 61-71
    • Beaumont, K.1    Smith, D.A.2
  • 18
    • 67650714101 scopus 로고    scopus 로고
    • In silico prediction of volume of distribution in human using linear and nonlinear models on a 669 compound data set
    • Berellini G, Springer C, Waters NJ, and Lombardo F (2009) In silico prediction of volume of distribution in human using linear and nonlinear models on a 669 compound data set. J Med Chem 52:4488-4495.
    • (2009) J Med Chem , vol.52 , pp. 4488-4495
    • Berellini, G.1    Springer, C.2    Waters, N.J.3    Lombardo, F.4
  • 19
    • 2642536176 scopus 로고    scopus 로고
    • Volume of distribution at steady state for a linear pharmacokinetic system with peripheral elimination
    • Berezhkovskiy LM (2004) Volume of distribution at steady state for a linear pharmacokinetic system with peripheral elimination. J Pharm Sci 93:1628-1640.
    • (2004) J Pharm Sci , vol.93 , pp. 1628-1640
    • Berezhkovskiy, L.M.1
  • 20
    • 84862516296 scopus 로고    scopus 로고
    • On the accuracy of determination of unbound drug fraction in tissue using diluted tissue homogenate
    • Berezhkovskiy LM (2012) On the accuracy of determination of unbound drug fraction in tissue using diluted tissue homogenate. J Pharm Sci 101:1909-1916.
    • (2012) J Pharm Sci , vol.101 , pp. 1909-1916
    • Berezhkovskiy, L.M.1
  • 22
    • 80054752374 scopus 로고    scopus 로고
    • Species differences in distribution and prediction of human V (ss) from preclinical data
    • Berry LM, Li C, and Zhao Z (2011) Species differences in distribution and prediction of human V (ss) from preclinical data. Drug Metab Dispos 39:2103-2116.
    • (2011) Drug Metab Dispos , vol.39 , pp. 2103-2116
    • Berry, L.M.1    Li, C.2    Zhao, Z.3
  • 23
    • 0034655372 scopus 로고    scopus 로고
    • A high-throughput screening method for the determination of aqueous drug solubility using laser nephelometry in microtiter plates
    • Bevan CD and Lloyd RS (2000) A high-throughput screening method for the determination of aqueous drug solubility using laser nephelometry in microtiter plates. Anal Chem 72: 1781-1787.
    • (2000) Anal Chem , vol.72 , pp. 1781-1787
    • Bevan, C.D.1    Lloyd, R.S.2
  • 24
    • 33747841593 scopus 로고    scopus 로고
    • Use of cryopreserved human hepatocytes in sandwich culture to measure hepatobiliary transport
    • Bi YA, Kazolias D, and Duignan DB (2006) Use of cryopreserved human hepatocytes in sandwich culture to measure hepatobiliary transport. Drug Metab Dispos 34:1658-1665.
    • (2006) Drug Metab Dispos , vol.34 , pp. 1658-1665
    • Bi, Y.A.1    Kazolias, D.2    Duignan, D.B.3
  • 25
    • 84859908239 scopus 로고    scopus 로고
    • In vitro evaluation of hepatic transporter-mediated clinical drug-drug interactions: Hepatocyte model optimization and retrospective investigation
    • Bi YA, Kimoto E, Sevidal S, Jones HM, Barton HA, Kempshall S, Whalen KM, Zhang H, Ji C, and Fenner KS, et al. (2012) In vitro evaluation of hepatic transporter-mediated clinical drug-drug interactions: hepatocyte model optimization and retrospective investigation. Drug Metab Dispos 40:1085-1092.
    • (2012) Drug Metab Dispos , vol.40 , pp. 1085-1092
    • Bi, Y.A.1    Kimoto, E.2    Sevidal, S.3    Jones, H.M.4    Barton, H.A.5    Kempshall, S.6    Whalen, K.M.7    Zhang, H.8    Ji, C.9    Fenner, K.S.10
  • 26
    • 10744232330 scopus 로고    scopus 로고
    • The conduct of in vitro and in vivo drug-drug interaction studies: A Pharmaceutical Research and Manufacturers of America (PhRMA) perspective
    • Pharmaceutical Research and Manufacturers of America (PhRMA) Drug Metabolism/Clinical Pharmacology Technical Working Group; ; FDA Center for Drug Evaluation and Research (CDER)
    • Bjornsson TD, Callaghan JT, Einolf HJ, Fischer V, Gan L, Grimm S, Kao J, King SP, Miwa G, and Ni L, et al.; Pharmaceutical Research and Manufacturers of America (PhRMA) Drug Metabolism/Clinical Pharmacology Technical Working Group; ; FDA Center for Drug Evaluation and Research (CDER) (2003) The conduct of in vitro and in vivo drug-drug interaction studies: a Pharmaceutical Research and Manufacturers of America (PhRMA) perspective. Drug Metab Dispos 31:815-832.
    • (2003) Drug Metab Dispos , vol.31 , pp. 815-832
    • Bjornsson, T.D.1    Callaghan, J.T.2    Einolf, H.J.3    Fischer, V.4    Gan, L.5    Grimm, S.6    Kao, J.7    King, S.P.8    Miwa, G.9    Ni, L.10
  • 27
    • 84877870763 scopus 로고    scopus 로고
    • Optimizing the in vitro and clinical assessment of drug interaction risk by understanding co-medications in patient populations
    • Bloomer J, Derimanov G, Dumont E, Ellens H, and Matheny C (2013) Optimizing the in vitro and clinical assessment of drug interaction risk by understanding co-medications in patient populations. Expert Opin Drug Metab Toxicol 9:737-751.
    • (2013) Expert Opin Drug Metab Toxicol , vol.9 , pp. 737-751
    • Bloomer, J.1    Derimanov, G.2    Dumont, E.3    Ellens, H.4    Matheny, C.5
  • 28
    • 0019974098 scopus 로고
    • Interspecies scaling, allometry, physiological time, and the ground plan of pharmacokinetics
    • Boxenbaum H (1982) Interspecies scaling, allometry, physiological time, and the ground plan of pharmacokinetics. J Pharmacokinet Biopharm 10:201-227.
    • (1982) J Pharmacokinet Biopharm , vol.10 , pp. 201-227
    • Boxenbaum, H.1
  • 29
    • 3042575812 scopus 로고    scopus 로고
    • Allometric scaling of pharmacokinetic parameters in drug discovery: Can human CL, Vss and t1/2 be predicted from in-vivo rat data?
    • Caldwell GW, Masucci JA, Yan Z, and Hageman W (2004) Allometric scaling of pharmacokinetic parameters in drug discovery: can human CL, Vss and t1/2 be predicted from in-vivo rat data? Eur J Drug Metab Pharmacokinet 29:133-143.
    • (2004) Eur J Drug Metab Pharmacokinet , vol.29 , pp. 133-143
    • Caldwell, G.W.1    Masucci, J.A.2    Yan, Z.3    Hageman, W.4
  • 32
    • 3542995726 scopus 로고    scopus 로고
    • The complexities of hepatic drug transport: Current knowledge and emerging concepts
    • Chandra P and Brouwer KL (2004) The complexities of hepatic drug transport: current knowledge and emerging concepts. Pharm Res 21:719-735.
    • (2004) Pharm Res , vol.21 , pp. 719-735
    • Chandra, P.1    Brouwer, K.L.2
  • 33
    • 84862777396 scopus 로고    scopus 로고
    • Application of IVIVE and PBPK modeling in prospective prediction of clinical pharmacokinetics: Strategy and approach during the drug discovery phase with four case studies
    • Chen Y, Jin JY, Mukadam S, Malhi V, and Kenny JR (2012) Application of IVIVE and PBPK modeling in prospective prediction of clinical pharmacokinetics: strategy and approach during the drug discovery phase with four case studies. Biopharm Drug Dispos 33:85-98.
    • (2012) Biopharm Drug Dispos , vol.33 , pp. 85-98
    • Chen, Y.1    Jin, J.Y.2    Mukadam, S.3    Malhi, V.4    Kenny, J.R.5
  • 34
    • 79951930597 scopus 로고    scopus 로고
    • Utility of intersystem extrapolation factors in early reaction phenotyping and the quantitative extrapolation of human liver microsomal intrinsic clearance using recombinant cytochromes P450
    • Chen Y, Liu L, Nguyen K, and Fretland AJ (2011) Utility of intersystem extrapolation factors in early reaction phenotyping and the quantitative extrapolation of human liver microsomal intrinsic clearance using recombinant cytochromes P450. Drug Metab Dispos 39:373-382.
    • (2011) Drug Metab Dispos , vol.39 , pp. 373-382
    • Chen, Y.1    Liu, L.2    Nguyen, K.3    Fretland, A.J.4
  • 35
    • 68249152290 scopus 로고    scopus 로고
    • Prediction of hepatic clearance in human from in vitro data for successful drug development
    • Chiba M, Ishii Y, and Sugiyama Y (2009) Prediction of hepatic clearance in human from in vitro data for successful drug development. AAPS J 11:262-276.
    • (2009) AAPS J , vol.11 , pp. 262-276
    • Chiba, M.1    Ishii, Y.2    Sugiyama, Y.3
  • 36
    • 0031786518 scopus 로고    scopus 로고
    • Linear correlation of the fraction of oral dose absorbed of 64 drugs between humans and rats
    • Chiou WL and Barve A (1998) Linear correlation of the fraction of oral dose absorbed of 64 drugs between humans and rats. Pharm Res 15:1792-1795.
    • (1998) Pharm Res , vol.15 , pp. 1792-1795
    • Chiou, W.L.1    Barve, A.2
  • 37
    • 0036296060 scopus 로고    scopus 로고
    • Comparison of oral absorption and bioavailablity of drugs between monkey and human
    • Chiou WL and Buehler PW (2002) Comparison of oral absorption and bioavailablity of drugs between monkey and human. Pharm Res 19:868-874.
    • (2002) Pharm Res , vol.19 , pp. 868-874
    • Chiou, W.L.1    Buehler, P.W.2
  • 38
    • 0034017007 scopus 로고    scopus 로고
    • Evaluation of using dog as an animal model to study the fraction of oral dose absorbed of 43 drugs in humans
    • Chiou WL, Jeong HY, Chung SM, and Wu TC (2000) Evaluation of using dog as an animal model to study the fraction of oral dose absorbed of 43 drugs in humans. Pharm Res 17: 135-140.
    • (2000) Pharm Res , vol.17 , pp. 135-140
    • Chiou, W.L.1    Jeong, H.Y.2    Chung, S.M.3    Wu, T.C.4
  • 39
    • 67649404709 scopus 로고    scopus 로고
    • In vitro and in vivo induction of cytochrome p450: A survey of the current practices and recommendations: A pharmaceutical research and manufacturers of america perspective
    • Chu V, Einolf HJ, Evers R, Kumar G, Moore D, Ripp S, Silva J, Sinha V, Sinz M, and Skerjanec A (2009) In vitro and in vivo induction of cytochrome p450: a survey of the current practices and recommendations: a pharmaceutical research and manufacturers of america perspective. Drug Metab Dispos 37:1339-1354.
    • (2009) Drug Metab Dispos , vol.37 , pp. 1339-1354
    • Chu, V.1    Einolf, H.J.2    Evers, R.3    Kumar, G.4    Moore, D.5    Ripp, S.6    Silva, J.7    Sinha, V.8    Sinz, M.9    Skerjanec, A.10
  • 40
    • 0033984905 scopus 로고    scopus 로고
    • A new physiologically based, segregated-flow model to explain route-dependent intestinal metabolism
    • Cong D, Doherty M, and Pang KS (2000) A new physiologically based, segregated-flow model to explain route-dependent intestinal metabolism. Drug Metab Dispos 28:224-235.
    • (2000) Drug Metab Dispos , vol.28 , pp. 224-235
    • Cong, D.1    Doherty, M.2    Pang, K.S.3
  • 41
    • 79955023850 scopus 로고    scopus 로고
    • Prediction of human drug clearance by multiple metabolic pathways: Integration of hepatic and intestinal microsomal and cytosolic data
    • Cubitt HE, Houston JB, and Galetin A (2011) Prediction of human drug clearance by multiple metabolic pathways: integration of hepatic and intestinal microsomal and cytosolic data. Drug Metab Dispos 39:864-873.
    • (2011) Drug Metab Dispos , vol.39 , pp. 864-873
    • Cubitt, H.E.1    Houston, J.B.2    Galetin, A.3
  • 42
    • 79851476433 scopus 로고    scopus 로고
    • Interplay of metabolism and transport in determining oral drug absorption and gut wall metabolism: A simulation assessment using the "Advanced Dissolution, Absorption, Metabolism (ADAM)" model
    • Darwich AS, Neuhoff S, Jamei M, and Rostami-Hodjegan A (2010) Interplay of metabolism and transport in determining oral drug absorption and gut wall metabolism: a simulation assessment using the "Advanced Dissolution, Absorption, Metabolism (ADAM)" model. Curr Drug Metab 11:716-729.
    • (2010) Curr Drug Metab , vol.11 , pp. 716-729
    • Darwich, A.S.1    Neuhoff, S.2    Jamei, M.3    Rostami-Hodjegan, A.4
  • 47
    • 84873019348 scopus 로고    scopus 로고
    • Optimal sampling times for a drug and its metabolite using SIMCYP(®) simulations as prior information
    • Dumont C, Mentré F, Gaynor C, Brendel K, Gesson C, and Chenel M (2013) Optimal sampling times for a drug and its metabolite using SIMCYP(®) simulations as prior information. Clin Pharmacokinet 52:43-57.
    • (2013) Clin Pharmacokinet , vol.52 , pp. 43-57
    • Dumont, C.1    Mentré, F.2    Gaynor, C.3    Brendel, K.4    Gesson, C.5    Chenel, M.6
  • 48
    • 35648968125 scopus 로고    scopus 로고
    • Comparison of different approaches to predict metabolic drug-drug interactions
    • Einolf HJ (2007) Comparison of different approaches to predict metabolic drug-drug interactions. Xenobiotica 37:1257-1294.
    • (2007) Xenobiotica , vol.37 , pp. 1257-1294
    • Einolf, H.J.1
  • 49
    • 84867873811 scopus 로고    scopus 로고
    • Understanding the critical disposition pathways of statins to assess drug-drug interaction risk during drug development: It's not just about OATP1B1
    • Elsby R, Hilgendorf C, and Fenner K (2012) Understanding the critical disposition pathways of statins to assess drug-drug interaction risk during drug development: it's not just about OATP1B1. Clin Pharmacol Ther 92:584-598.
    • (2012) Clin Pharmacol Ther , vol.92 , pp. 584-598
    • Elsby, R.1    Hilgendorf, C.2    Fenner, K.3
  • 51
    • 79952343050 scopus 로고    scopus 로고
    • Methodologies for investigating drug metabolism at the early drug discovery stage: Prediction of hepatic drug clearance and P450 contribution
    • Emoto C, Murayama N, Rostami-Hodjegan A, and Yamazaki H (2010) Methodologies for investigating drug metabolism at the early drug discovery stage: prediction of hepatic drug clearance and P450 contribution. Curr Drug Metab 11:678-685.
    • (2010) Curr Drug Metab , vol.11 , pp. 678-685
    • Emoto, C.1    Murayama, N.2    Rostami-Hodjegan, A.3    Yamazaki, H.4
  • 52
    • 0029855969 scopus 로고    scopus 로고
    • Comparison between permeability coefficients in rat and human jejunum
    • Fagerholm U, Johansson M, and Lennernäs H (1996) Comparison between permeability coefficients in rat and human jejunum. Pharm Res 13:1336-1342.
    • (1996) Pharm Res , vol.13 , pp. 1336-1342
    • Fagerholm, U.1    Johansson, M.2    Lennernäs, H.3
  • 53
    • 67650825002 scopus 로고    scopus 로고
    • Comparison of different algorithms for predicting clinical drug-drug interactions, based on the use of CYP3A4 in vitro data: Predictions of compounds as precipitants of interaction
    • Fahmi OA, Hurst S, Plowchalk D, Cook J, Guo F, Youdim K, Dickins M, Phipps A, Darekar A, and Hyland R, et al. (2009) Comparison of different algorithms for predicting clinical drug-drug interactions, based on the use of CYP3A4 in vitro data: predictions of compounds as precipitants of interaction. Drug Metab Dispos 37:1658-1666.
    • (2009) Drug Metab Dispos , vol.37 , pp. 1658-1666
    • Fahmi, O.A.1    Hurst, S.2    Plowchalk, D.3    Cook, J.4    Guo, F.5    Youdim, K.6    Dickins, M.7    Phipps, A.8    Darekar, A.9    Hyland, R.10
  • 54
    • 77955999532 scopus 로고    scopus 로고
    • Cytochrome P450 3A4 mRNA is a more reliable marker than CYP3A4 activity for detecting pregnane X receptor-activated induction of drug-metabolizing enzymes
    • Fahmi OA, Kish M, Boldt S, and Obach RS (2010) Cytochrome P450 3A4 mRNA is a more reliable marker than CYP3A4 activity for detecting pregnane X receptor-activated induction of drug-metabolizing enzymes. Drug Metab Dispos 38:1605-1611.
    • (2010) Drug Metab Dispos , vol.38 , pp. 1605-1611
    • Fahmi, O.A.1    Kish, M.2    Boldt, S.3    Obach, R.S.4
  • 55
    • 47949115175 scopus 로고    scopus 로고
    • A combined model for predicting CYP3A4 clinical net drug-drug interaction based on CYP3A4 inhibition, inactivation, and induction determined in vitro
    • Fahmi OA, Maurer TS, Kish M, Cardenas E, Boldt S, and Nettleton D (2008) A combined model for predicting CYP3A4 clinical net drug-drug interaction based on CYP3A4 inhibition, inactivation, and induction determined in vitro. Drug Metab Dispos 36:1698-1708.
    • (2008) Drug Metab Dispos , vol.36 , pp. 1698-1708
    • Fahmi, O.A.1    Maurer, T.S.2    Kish, M.3    Cardenas, E.4    Boldt, S.5    Nettleton, D.6
  • 56
    • 77958498196 scopus 로고    scopus 로고
    • Evaluation of models for predicting drug-drug interactions due to induction
    • Fahmi OA and Ripp SL (2010) Evaluation of models for predicting drug-drug interactions due to induction. Expert Opin Drug Metab Toxicol 6:1399-1416.
    • (2010) Expert Opin Drug Metab Toxicol , vol.6 , pp. 1399-1416
    • Fahmi, O.A.1    Ripp, S.L.2
  • 57
    • 79951500920 scopus 로고    scopus 로고
    • PBPK modeling of intestinal and liver enzymes and transporters in drug absorption and sequential metabolism
    • Fan J, Chen S, Chow EC, and Pang KS (2010) PBPK modeling of intestinal and liver enzymes and transporters in drug absorption and sequential metabolism. Curr Drug Metab 11:743-761.
    • (2010) Curr Drug Metab , vol.11 , pp. 743-761
    • Fan, J.1    Chen, S.2    Chow, E.C.3    Pang, K.S.4
  • 59
    • 58549088199 scopus 로고    scopus 로고
    • Drug-drug interactions mediated through P-glycoprotein: Clinical relevance and in vitro-in vivo correlation using digoxin as a probe drug
    • Fenner KS, Troutman MD, Kempshall S, Cook JA, Ware JA, Smith DA, and Lee CA (2009) Drug-drug interactions mediated through P-glycoprotein: clinical relevance and in vitro-in vivo correlation using digoxin as a probe drug. Clin Pharmacol Ther 85:173-181.
    • (2009) Clin Pharmacol Ther , vol.85 , pp. 173-181
    • Fenner, K.S.1    Troutman, M.D.2    Kempshall, S.3    Cook, J.A.4    Ware, J.A.5    Smith, D.A.6    Lee, C.A.7
  • 60
    • 46449095993 scopus 로고    scopus 로고
    • Effect of plasma protein binding on in vitro-in vivo correlation of biliary excretion of drugs evaluated by sandwich-cultured rat hepatocytes
    • Fukuda H, Ohashi R, Tsuda-Tsukimoto M, and Tamai I (2008) Effect of plasma protein binding on in vitro-in vivo correlation of biliary excretion of drugs evaluated by sandwich-cultured rat hepatocytes. Drug Metab Dispos 36:1275-1282.
    • (2008) Drug Metab Dispos , vol.36 , pp. 1275-1282
    • Fukuda, H.1    Ohashi, R.2    Tsuda-Tsukimoto, M.3    Tamai, I.4
  • 61
    • 84878824845 scopus 로고    scopus 로고
    • Cyclosporine inhibition of hepatic and intestinal CYP3A4, uptake and efflux transporters: Application of PBPK modeling in the assessment of drug-drug interaction potential
    • Gertz M, Cartwright CM, Hobbs MJ, Kenworthy KE, Rowland M, Houston JB, and Galetin A (2013) Cyclosporine inhibition of hepatic and intestinal CYP3A4, uptake and efflux transporters: application of PBPK modeling in the assessment of drug-drug interaction potential. Pharm Res 30:761-780.
    • (2013) Pharm Res , vol.30 , pp. 761-780
    • Gertz, M.1    Cartwright, C.M.2    Hobbs, M.J.3    Kenworthy, K.E.4    Rowland, M.5    Houston, J.B.6    Galetin, A.7
  • 62
    • 77953737073 scopus 로고    scopus 로고
    • Prediction of human intestinal first-pass metabolism of 25 CYP3A substrates from in vitro clearance and permeability data
    • Gertz M, Harrison A, Houston JB, and Galetin A (2010) Prediction of human intestinal first-pass metabolism of 25 CYP3A substrates from in vitro clearance and permeability data. Drug Metab Dispos 38:1147-1158.
    • (2010) Drug Metab Dispos , vol.38 , pp. 1147-1158
    • Gertz, M.1    Harrison, A.2    Houston, J.B.3    Galetin, A.4
  • 63
    • 1642306443 scopus 로고    scopus 로고
    • Quantitative structure-pharmacokinetic relationship modelling: Apparent volume of distribution
    • Ghafourian T, Barzegar-Jalali M, Hakimiha N, and Cronin MTD (2004) Quantitative structure-pharmacokinetic relationship modelling: apparent volume of distribution. J Pharm Pharmacol 56:339-350.
    • (2004) J Pharm Pharmacol , vol.56 , pp. 339-350
    • Ghafourian, T.1    Barzegar-Jalali, M.2    Hakimiha, N.3    Cronin, M.T.D.4
  • 67
    • 84887231773 scopus 로고    scopus 로고
    • Using human recombinant UDP-glucuronosyltransferase isoforms and a relative activity factor approach to model total body clearance of laropiprant (MK-0524) in humans
    • DOI: 10.3109/00498254.2013.791761 [published ahead of print]
    • Gibson CR, Lu P, Maciolek C, Wudarski C, Barter Z, Rowland-Yeo K, Stroh M, Lai E, and Nicoll-Griffith DA (2013) Using human recombinant UDP-glucuronosyltransferase isoforms and a relative activity factor approach to model total body clearance of laropiprant (MK-0524) in humans. Xenobiotica DOI: 10.3109/00498254.2013.791761 [published ahead of print].
    • (2013) Xenobiotica
    • Gibson, C.R.1    Lu, P.2    Maciolek, C.3    Wudarski, C.4    Barter, Z.5    Rowland-Yeo, K.6    Stroh, M.7    Lai, E.8    Nicoll-Griffith, D.A.9
  • 68
    • 0015212973 scopus 로고
    • Factors affecting drug metabolism
    • Gillette JR (1971) Factors affecting drug metabolism. Ann N Y Acad Sci 179:43-66.
    • (1971) Ann N Y Acad Sci , vol.179 , pp. 43-66
    • Gillette, J.R.1
  • 69
    • 33645404135 scopus 로고    scopus 로고
    • In silico human and rat Vss quantitative structure-activity relationship models
    • Gleeson MP, Waters NJ, Paine SW, and Davis AM (2006) In silico human and rat Vss quantitative structure-activity relationship models. J Med Chem 49:1953-1963.
    • (2006) J Med Chem , vol.49 , pp. 1953-1963
    • Gleeson, M.P.1    Waters, N.J.2    Paine, S.W.3    Davis, A.M.4
  • 70
    • 84877079740 scopus 로고    scopus 로고
    • In vivo quantitative prediction of the effect of gene polymorphisms and drug interactions on drug exposure for CYP2C19 substrates
    • Goutelle S, Bourguignon L, Bleyzac N, Berry J, Clavel-Grabit F, and Tod M (2013) In vivo quantitative prediction of the effect of gene polymorphisms and drug interactions on drug exposure for CYP2C19 substrates. AAPS J 15:415-426.
    • (2013) AAPS J , vol.15 , pp. 415-426
    • Goutelle, S.1    Bourguignon, L.2    Bleyzac, N.3    Berry, J.4    Clavel-Grabit, F.5    Tod, M.6
  • 71
    • 68149151186 scopus 로고    scopus 로고
    • Effects of drug transporters on volume of distribution
    • Grover A and Benet LZ (2009) Effects of drug transporters on volume of distribution. AAPS J 11:250-261.
    • (2009) AAPS J , vol.11 , pp. 250-261
    • Grover, A.1    Benet, L.Z.2
  • 72
    • 78650016675 scopus 로고    scopus 로고
    • Assessment of algorithms for predicting drug-drug interactions via inhibition mechanisms: Comparison of dynamic and static models
    • Guest EJ, Rowland-Yeo K, Rostami-Hodjegan A, Tucker GT, Houston JB, and Galetin A (2011) Assessment of algorithms for predicting drug-drug interactions via inhibition mechanisms: comparison of dynamic and static models. Br J Clin Pharmacol 71:72-87.
    • (2011) Br J Clin Pharmacol , vol.71 , pp. 72-87
    • Guest, E.J.1    Rowland-Yeo, K.2    Rostami-Hodjegan, A.3    Tucker, G.T.4    Houston, J.B.5    Galetin, A.6
  • 73
    • 78049375674 scopus 로고    scopus 로고
    • General review on in vitro hepatocyte models and their applications
    • Guguen-Guillouzo C and Guillouzo A (2010) General review on in vitro hepatocyte models and their applications. Methods Mol Biol 640:1-40.
    • (2010) Methods Mol Biol , vol.640 , pp. 1-40
    • Guguen-Guillouzo, C.1    Guillouzo, A.2
  • 74
    • 78049385182 scopus 로고    scopus 로고
    • Using open source computational tools for predicting human metabolic stability and additional absorption, distribution, metabolism, excretion, and toxicity properties
    • Gupta RR, Gifford EM, Liston T, Waller CL, Hohman M, Bunin BA, and Ekins S (2010) Using open source computational tools for predicting human metabolic stability and additional absorption, distribution, metabolism, excretion, and toxicity properties. Drug Metab Dispos 38:2083-2090.
    • (2010) Drug Metab Dispos , vol.38 , pp. 2083-2090
    • Gupta, R.R.1    Gifford, E.M.2    Liston, T.3    Waller, C.L.4    Hohman, M.5    Bunin, B.A.6    Ekins, S.7
  • 75
    • 77957344287 scopus 로고    scopus 로고
    • Prediction of human metabolic clearance from in vitro systems: Retrospective analysis and prospective view
    • Hallifax D, Foster JA, and Houstion JB (2010) Prediction of human metabolic clearance from in vitro systems: retrospective analysis and prospective view. Pharm Res 27:2150-2161.
    • (2010) Pharm Res , vol.27 , pp. 2150-2161
    • Hallifax, D.1    Foster, J.A.2    Houstion, J.B.3
  • 76
    • 84855405567 scopus 로고    scopus 로고
    • Quantification of human uridine-diphosphate glucuronosyl transferase 1A isoforms in liver, intestine, and kidney using nanobore liquid chromatography-tandem mass spectrometry
    • Harbourt DE, Fallon JK, Ito S, Baba T, Ritter JK, Glish GL, and Smith PC (2012) Quantification of human uridine-diphosphate glucuronosyl transferase 1A isoforms in liver, intestine, and kidney using nanobore liquid chromatography-tandem mass spectrometry. Anal Chem 84:98-105.
    • (2012) Anal Chem , vol.84 , pp. 98-105
    • Harbourt, D.E.1    Fallon, J.K.2    Ito, S.3    Baba, T.4    Ritter, J.K.5    Glish, G.L.6    Smith, P.C.7
  • 77
    • 33845370513 scopus 로고    scopus 로고
    • Estimation of volume of distribution in humans from high throughput HPLC-based measurements of human serum albumin binding and immobilized artificial membrane partitioning
    • Hollósy F, Valkó K, Hersey A, Nunhuck S, Kéri G, and Bevan C (2006) Estimation of volume of distribution in humans from high throughput HPLC-based measurements of human serum albumin binding and immobilized artificial membrane partitioning. J Med Chem 49:6958-6971.
    • (2006) J Med Chem , vol.49 , pp. 6958-6971
    • Hollósy, F.1    Valkó, K.2    Hersey, A.3    Nunhuck, S.4    Kéri, G.5    Bevan, C.6
  • 79
    • 0028342648 scopus 로고
    • Utility of in vitro drug metabolism data in predicting in vivo metabolic clearance
    • Houston JB (1994) Utility of in vitro drug metabolism data in predicting in vivo metabolic clearance. Biochem Pharmacol 47:1469-1479.
    • (1994) Biochem Pharmacol , vol.47 , pp. 1469-1479
    • Houston, J.B.1
  • 80
    • 84862777920 scopus 로고    scopus 로고
    • The role of physiologically based pharmacokinetic modeling in regulatory review
    • Huang SM and Rowland M (2012) The role of physiologically based pharmacokinetic modeling in regulatory review. Clin Pharmacol Ther 91:542-549.
    • (2012) Clin Pharmacol Ther , vol.91 , pp. 542-549
    • Huang, S.M.1    Rowland, M.2
  • 84
    • 18844369894 scopus 로고    scopus 로고
    • Impact of parallel pathways of drug elimination and multiple cytochrome P450 involvement on drug-drug interactions: CYP2D6 paradigm
    • Ito K, Hallifax D, Obach RS, and Houston JB (2005) Impact of parallel pathways of drug elimination and multiple cytochrome P450 involvement on drug-drug interactions: CYP2D6 paradigm. Drug Metab Dispos 33:837-844.
    • (2005) Drug Metab Dispos , vol.33 , pp. 837-844
    • Ito, K.1    Hallifax, D.2    Obach, R.S.3    Houston, J.B.4
  • 89
    • 0028206698 scopus 로고
    • Fluconazole: Interspecies scaling and allometric relationships of pharmacokinetic properties
    • Jezequel SG (1994) Fluconazole: interspecies scaling and allometric relationships of pharmacokinetic properties. J Pharm Pharmacol 46:196-199.
    • (1994) J Pharm Pharmacol , vol.46 , pp. 196-199
    • Jezequel, S.G.1
  • 90
    • 84863968343 scopus 로고    scopus 로고
    • Utility of drug depletion-time profiles in isolated hepatocytes for accessing hepatic uptake clearance: Identifying rate-limiting steps and role of passive processes
    • Jigorel E and Houston JB (2012) Utility of drug depletion-time profiles in isolated hepatocytes for accessing hepatic uptake clearance: identifying rate-limiting steps and role of passive processes. Drug Metab Dispos 40:1596-1602.
    • (2012) Drug Metab Dispos , vol.40 , pp. 1596-1602
    • Jigorel, E.1    Houston, J.B.2
  • 91
  • 93
    • 80052267476 scopus 로고    scopus 로고
    • PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 2: Comparative assessment of prediction methods of human volume of distribution
    • Jones RD, Jones HM, Rowland M, Gibson CR, Yates JW, Chien JY, Ring BJ, Adkison KK, Ku MS, and He H, et al.. (2011b) PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 2: Comparative assessment of prediction methods of human volume of distribution. J Pharm Sci 100:4074-4089.
    • (2011) J Pharm Sci , vol.100 , pp. 4074-4089
    • Jones, R.D.1    Jones, H.M.2    Rowland, M.3    Gibson, C.R.4    Yates, J.W.5    Chien, J.Y.6    Ring, B.J.7    Adkison, K.K.8    Ku, M.S.9    He, H.10
  • 94
    • 56149107690 scopus 로고    scopus 로고
    • Effects of gemfibrozil and atorvastatin on the pharmacokinetics of repaglinide in relation to SLCO1B1 polymorphism
    • Kalliokoski A, Backman JT, Kurkinen KJ, Neuvonen PJ, and Niemi M (2008) Effects of gemfibrozil and atorvastatin on the pharmacokinetics of repaglinide in relation to SLCO1B1 polymorphism. Clin Pharmacol Ther 84:488-496.
    • (2008) Clin Pharmacol Ther , vol.84 , pp. 488-496
    • Kalliokoski, A.1    Backman, J.T.2    Kurkinen, K.J.3    Neuvonen, P.J.4    Niemi, M.5
  • 95
    • 0030638506 scopus 로고    scopus 로고
    • Hepatic canalicular membrane. Introduction: Transport across the hepatocyte canalicular membrane
    • Keppler D and Arias IM (1997) Hepatic canalicular membrane. Introduction: transport across the hepatocyte canalicular membrane. FASEB J 11:15-18.
    • (1997) FASEB J , vol.11 , pp. 15-18
    • Keppler, D.1    Arias, I.M.2
  • 96
    • 0030752006 scopus 로고    scopus 로고
    • Transport of glutathione conjugates and glucuronides by the multidrug resistance proteins MRP1 and MRP2
    • Keppler D, Leier I, and Jedlitschky G (1997) Transport of glutathione conjugates and glucuronides by the multidrug resistance proteins MRP1 and MRP2. Biol Chem 378:787-791.
    • (1997) Biol Chem , vol.378 , pp. 787-791
    • Keppler, D.1    Leier, I.2    Jedlitschky, G.3
  • 97
    • 15244342411 scopus 로고    scopus 로고
    • UDP-glucuronosyltransferases and clinical drug-drug interactions
    • Kiang TK, Ensom MH, and Chang TK (2005) UDP-glucuronosyltransferases and clinical drug-drug interactions. Pharmacol Ther 106:97-132.
    • (2005) Pharmacol Ther , vol.106 , pp. 97-132
    • Kiang, T.K.1    Ensom, M.H.2    Chang, T.K.3
  • 98
    • 58149472377 scopus 로고    scopus 로고
    • Prediction of drug clearance by glucuronidation from in vitro data: Use of combined cytochrome P450 and UDP-glucuronosyltransferase cofactors in alamethicin-activated human liver microsomes
    • Kilford PJ, Stringer R, Sohal B, Houston JB, and Galetin A (2009) Prediction of drug clearance by glucuronidation from in vitro data: use of combined cytochrome P450 and UDP-glucuronosyltransferase cofactors in alamethicin-activated human liver microsomes. Drug Metab Dispos 37:82-89.
    • (2009) Drug Metab Dispos , vol.37 , pp. 82-89
    • Kilford, P.J.1    Stringer, R.2    Sohal, B.3    Houston, J.B.4    Galetin, A.5
  • 99
    • 78650730960 scopus 로고    scopus 로고
    • Characterization of digoxin uptake in sandwich-cultured human hepatocytes
    • Kimoto E, Chupka J, Xiao Y, Bi YA, and Duignan DB (2011) Characterization of digoxin uptake in sandwich-cultured human hepatocytes. Drug Metab Dispos 39:47-53.
    • (2011) Drug Metab Dispos , vol.39 , pp. 47-53
    • Kimoto, E.1    Chupka, J.2    Xiao, Y.3    Bi, Y.A.4    Duignan, D.B.5
  • 100
    • 84862934885 scopus 로고    scopus 로고
    • Differential modulation of cytochrome P450 activity and the effect of 1-aminobenzotriazole on hepatic transport in sandwich-cultured human hepatocytes
    • Kimoto E, Walsky R, Zhang H, Bi YA, Whalen KM, Yang YS, Linder C, Xiao Y, Iseki K, and Fenner KS, et al. (2012a) Differential modulation of cytochrome P450 activity and the effect of 1-aminobenzotriazole on hepatic transport in sandwich-cultured human hepatocytes. Drug Metab Dispos 40:407-411.
    • (2012) Drug Metab Dispos , vol.40 , pp. 407-411
    • Kimoto, E.1    Walsky, R.2    Zhang, H.3    Bi, Y.A.4    Whalen, K.M.5    Yang, Y.S.6    Linder, C.7    Xiao, Y.8    Iseki, K.9    Fenner, K.S.10
  • 101
    • 84870539183 scopus 로고    scopus 로고
    • Characterization of Organic Anion Transporting Polypeptide (OATP) Expression and Its Functional Contribution to the Uptake of Substrates in Human Hepatocytes
    • Kimoto E, Yoshida K, Balogh LM, Bi YA, Maeda K, El-Kattan A, Sugiyama Y, and Lai Y (2012b) Characterization of Organic Anion Transporting Polypeptide (OATP) Expression and Its Functional Contribution to the Uptake of Substrates in Human Hepatocytes. Mol Pharm 9:3535-3542.
    • (2012) Mol Pharm , vol.9 , pp. 3535-3542
    • Kimoto, E.1    Yoshida, K.2    Balogh, L.M.3    Bi, Y.A.4    Maeda, K.5    El-Kattan, A.6    Sugiyama, Y.7    Lai, Y.8
  • 102
    • 4344645978 scopus 로고    scopus 로고
    • Can the pharmaceutical industry reduce attrition rates?
    • Kola I and Landis J (2004) Can the pharmaceutical industry reduce attrition rates? Nat Rev Drug Discov 3:711-715.
    • (2004) Nat Rev Drug Discov , vol.3 , pp. 711-715
    • Kola, I.1    Landis, J.2
  • 104
    • 59949086334 scopus 로고    scopus 로고
    • Application of allometry principles for the prediction of human pharmacokinetic parameters for irbesartan, a AT1 receptor antagonist, from animal data
    • Kumar VV and Srinivas NR (2008) Application of allometry principles for the prediction of human pharmacokinetic parameters for irbesartan, a AT1 receptor antagonist, from animal data. Eur J Drug Metab Pharmacokinet 33:247-252.
    • (2008) Eur J Drug Metab Pharmacokinet , vol.33 , pp. 247-252
    • Kumar, V.V.1    Srinivas, N.R.2
  • 105
    • 66449128354 scopus 로고    scopus 로고
    • In vitro-in vivo extrapolation of transporter-mediated clearance in the liver and kidney
    • Kusuhara H and Sugiyama Y (2009) In vitro-in vivo extrapolation of transporter-mediated clearance in the liver and kidney. Drug Metab Pharmacokinet 24:37-52.
    • (2009) Drug Metab Pharmacokinet , vol.24 , pp. 37-52
    • Kusuhara, H.1    Sugiyama, Y.2
  • 106
    • 70349399011 scopus 로고    scopus 로고
    • Identification of interspecies difference in hepatobiliary transporters to improve extrapolation of human biliary secretion
    • Lai Y (2009) Identification of interspecies difference in hepatobiliary transporters to improve extrapolation of human biliary secretion. Expert Opin Drug Metab Toxicol 5:1175-1187.
    • (2009) Expert Opin Drug Metab Toxicol , vol.5 , pp. 1175-1187
    • Lai, Y.1
  • 108
    • 6944219986 scopus 로고    scopus 로고
    • Hepatic microsome studies are insufficient to characterize in vivo hepatic metabolic clearance and metabolic drug-drug interactions: Studies of digoxin metabolism in primary rat hepatocytes versus microsomes
    • Lam JL and Benet LZ (2004) Hepatic microsome studies are insufficient to characterize in vivo hepatic metabolic clearance and metabolic drug-drug interactions: studies of digoxin metabolism in primary rat hepatocytes versus microsomes. Drug Metab Dispos 32:1311-1316.
    • (2004) Drug Metab Dispos , vol.32 , pp. 1311-1316
    • Lam, J.L.1    Benet, L.Z.2
  • 109
    • 0032921527 scopus 로고    scopus 로고
    • Prediction of hepatic metabolic clearance based on interspecies allometric scaling techniques and in vitro-in vivo correlations
    • Lavé T, Coassolo P, and Reigner B (1999) Prediction of hepatic metabolic clearance based on interspecies allometric scaling techniques and in vitro-in vivo correlations. Clin Pharmacokinet 36:211-231.
    • (1999) Clin Pharmacokinet , vol.36 , pp. 211-231
    • Lavé, T.1    Coassolo, P.2    Reigner, B.3
  • 110
    • 0030918716 scopus 로고    scopus 로고
    • Integration of in vitro data into allometric scaling to predict hepatic metabolic clearance in man: Application to 10 extensively metabolized drugs
    • Lave T, Dupin S, Schmitt C, Chou RC, Jaeck D, and Coassolo P (1997) Integration of in vitro data into allometric scaling to predict hepatic metabolic clearance in man: application to 10 extensively metabolized drugs. J Pharm Sci 86:584-590.
    • (1997) J Pharm Sci , vol.86 , pp. 584-590
    • Lave, T.1    Dupin, S.2    Schmitt, C.3    Chou, R.C.4    Jaeck, D.5    Coassolo, P.6
  • 111
    • 48849087036 scopus 로고    scopus 로고
    • Identification of interspecies difference in efflux transporters of hepatocytes from dog, rat, monkey and human
    • Li M, Yuan H, Li N, Song G, Zheng Y, Baratta M, Hua F, Thurston A, Wang J, and Lai Y (2008) Identification of interspecies difference in efflux transporters of hepatocytes from dog, rat, monkey and human. Eur J Pharm Sci 35:114-126.
    • (2008) Eur J Pharm Sci , vol.35 , pp. 114-126
    • Li, M.1    Yuan, H.2    Li, N.3    Song, G.4    Zheng, Y.5    Baratta, M.6    Hua, F.7    Thurston, A.8    Wang, J.9    Lai, Y.10
  • 112
    • 77953284053 scopus 로고    scopus 로고
    • Improved extrapolation of hepatobiliary clearance from in vitro sandwich cultured rat hepatocytes through absolute quantification of hepatobiliary transporters
    • Li N, Singh P, Mandrell KM, and Lai Y (2010) Improved extrapolation of hepatobiliary clearance from in vitro sandwich cultured rat hepatocytes through absolute quantification of hepatobiliary transporters. Mol Pharm 7:630-641.
    • (2010) Mol Pharm , vol.7 , pp. 630-641
    • Li, N.1    Singh, P.2    Mandrell, K.M.3    Lai, Y.4
  • 113
    • 0028818229 scopus 로고
    • Species similarities and differences in pharmacokinetics
    • Lin JH (1995) Species similarities and differences in pharmacokinetics. Drug Metab Dispos 23:1008-1021.
    • (1995) Drug Metab Dispos , vol.23 , pp. 1008-1021
    • Lin, J.H.1
  • 114
    • 11144276585 scopus 로고    scopus 로고
    • The roles of transporters and enzymes in hepatic drug processing
    • Liu L and Pang KS (2005) The roles of transporters and enzymes in hepatic drug processing. Drug Metab Dispos 33:1-9.
    • (2005) Drug Metab Dispos , vol.33 , pp. 1-9
    • Liu, L.1    Pang, K.S.2
  • 115
    • 0033017134 scopus 로고    scopus 로고
    • Correlation of biliary excretion in sandwich-cultured rat hepatocytes and in vivo in rats
    • Liu X, Chism JP, LeCluyse EL, Brouwer KR, and Brouwer KL (1999) Correlation of biliary excretion in sandwich-cultured rat hepatocytes and in vivo in rats. Drug Metab Dispos 27:637-644.
    • (1999) Drug Metab Dispos , vol.27 , pp. 637-644
    • Liu, X.1    Chism, J.P.2    LeCluyse, E.L.3    Brouwer, K.R.4    Brouwer, K.L.5
  • 116
    • 33645675081 scopus 로고    scopus 로고
    • A hybrid mixture discriminant analysis-random forest computational model for the prediction of volume of distribution of drugs in human
    • Lombardo F, Obach RS, Dicapua FM, Bakken GA, Lu J, Potter DM, Gao F, Miller MD, and Zhang Y (2006) A hybrid mixture discriminant analysis-random forest computational model for the prediction of volume of distribution of drugs in human. J Med Chem 49:2262-2267.
    • (2006) J Med Chem , vol.49 , pp. 2262-2267
    • Lombardo, F.1    Obach, R.S.2    Dicapua, F.M.3    Bakken, G.A.4    Lu, J.5    Potter, D.M.6    Gao, F.7    Miller, M.D.8    Zhang, Y.9
  • 119
  • 120
    • 0032553486 scopus 로고    scopus 로고
    • Interspecies scaling of renally secreted drugs
    • Mahmood I (1998) Interspecies scaling of renally secreted drugs. Life Sci 63:2365-2371.
    • (1998) Life Sci , vol.63 , pp. 2365-2371
    • Mahmood, I.1
  • 121
    • 0032822442 scopus 로고    scopus 로고
    • Prediction of clearance, volume of distribution and half-life by allometric scaling and by use of plasma concentrations predicted from pharmacokinetic constants: A comparative study
    • Mahmood I (1999) Prediction of clearance, volume of distribution and half-life by allometric scaling and by use of plasma concentrations predicted from pharmacokinetic constants: a comparative study. J Pharm Pharmacol 51:905-910.
    • (1999) J Pharm Pharmacol , vol.51 , pp. 905-910
    • Mahmood, I.1
  • 122
    • 0035209269 scopus 로고    scopus 로고
    • Mechanisms and clinical implications of renal drug excretion
    • Masereeuw R and Russel FG (2001) Mechanisms and clinical implications of renal drug excretion. Drug Metab Rev 33:299-351.
    • (2001) Drug Metab Rev , vol.33 , pp. 299-351
    • Masereeuw, R.1    Russel, F.G.2
  • 123
    • 84865191410 scopus 로고    scopus 로고
    • Use of mechanistic modeling to assess interindividual variability and interspecies differences in active uptake in human and rat hepatocytes
    • Ménochet K, Kenworthy KE, Houston JB, and Galetin A (2012) Use of mechanistic modeling to assess interindividual variability and interspecies differences in active uptake in human and rat hepatocytes. Drug Metab Dispos 40:1744-1756.
    • (2012) Drug Metab Dispos , vol.40 , pp. 1744-1756
    • Ménochet, K.1    Kenworthy, K.E.2    Houston, J.B.3    Galetin, A.4
  • 124
    • 0023033053 scopus 로고
    • Man versus beast: Pharmacokinetic scaling in mammals
    • Mordenti J (1986) Man versus beast: pharmacokinetic scaling in mammals. J Pharm Sci 75:1028-1040.
    • (1986) J Pharm Sci , vol.75 , pp. 1028-1040
    • Mordenti, J.1
  • 125
    • 0030753125 scopus 로고    scopus 로고
    • Molecular aspects of hepatobiliary transport
    • Müller M and Jansen PL (1997) Molecular aspects of hepatobiliary transport. Am J Physiol 272:G1285-G1303.
    • (1997) Am J Physiol , vol.272
    • Müller, M.1    Jansen, P.L.2
  • 127
    • 79953901458 scopus 로고    scopus 로고
    • Organic anion transporting polypeptide 1B1: A genetically polymorphic transporter of major importance for hepatic drug uptake
    • Niemi M, Pasanen MK, and Neuvonen PJ (2011) Organic anion transporting polypeptide 1B1: a genetically polymorphic transporter of major importance for hepatic drug uptake. Pharmacol Rev 63:157-181.
    • (2011) Pharmacol Rev , vol.63 , pp. 157-181
    • Niemi, M.1    Pasanen, M.K.2    Neuvonen, P.J.3
  • 128
    • 78049367110 scopus 로고    scopus 로고
    • Prediction of the intestinal first-pass metabolism of CYP3A substrates in humans using cynomolgus monkeys
    • Nishimuta H, Sato K, Mizuki Y, Yabuki M, and Komuro S (2010) Prediction of the intestinal first-pass metabolism of CYP3A substrates in humans using cynomolgus monkeys. Drug Metab Dispos 38:1967-1975.
    • (2010) Drug Metab Dispos , vol.38 , pp. 1967-1975
    • Nishimuta, H.1    Sato, K.2    Mizuki, Y.3    Yabuki, M.4    Komuro, S.5
  • 129
    • 0031466149 scopus 로고    scopus 로고
    • Nonspecific binding to microsomes: Impact on scale-up of in vitro intrinsic clearance to hepatic clearance as assessed through examination of warfarin, imipramine, and propranolol
    • Obach RS (1997) Nonspecific binding to microsomes: impact on scale-up of in vitro intrinsic clearance to hepatic clearance as assessed through examination of warfarin, imipramine, and propranolol. Drug Metab Dispos 25:1359-1369.
    • (1997) Drug Metab Dispos , vol.25 , pp. 1359-1369
    • Obach, R.S.1
  • 130
    • 0032733974 scopus 로고    scopus 로고
    • Prediction of human clearance of twenty-nine drugs from hepatic microsomal intrinsic clearance data: An examination of in vitro half-life approach and nonspecific binding to microsomes
    • Obach RS (1999) Prediction of human clearance of twenty-nine drugs from hepatic microsomal intrinsic clearance data: An examination of in vitro half-life approach and nonspecific binding to microsomes. Drug Metab Dispos 27:1350-1359.
    • (1999) Drug Metab Dispos , vol.27 , pp. 1350-1359
    • Obach, R.S.1
  • 131
    • 0033840074 scopus 로고    scopus 로고
    • Metabolism of ezlopitant, a nonpeptidic substance P receptor antagonist, in liver microsomes: Enzyme kinetics, cytochrome P450 isoform identity, and in vitro-in vivo correlation
    • Obach RS (2000) Metabolism of ezlopitant, a nonpeptidic substance P receptor antagonist, in liver microsomes: enzyme kinetics, cytochrome P450 isoform identity, and in vitro-in vivo correlation. Drug Metab Dispos 28:1069-1076.
    • (2000) Drug Metab Dispos , vol.28 , pp. 1069-1076
    • Obach, R.S.1
  • 132
    • 35748934513 scopus 로고    scopus 로고
    • Prediction of human volume of distribution using in vivo, in vitro, and in silico approaches
    • Obach RS (2007) Prediction of human volume of distribution using in vivo, in vitro, and in silico approaches. Annu Rep Med Chem 42:469-488.
    • (2007) Annu Rep Med Chem , vol.42 , pp. 469-488
    • Obach, R.S.1
  • 133
    • 58449091215 scopus 로고    scopus 로고
    • Predicting drug-drug interactions from in vitro drug metabolism data: Challenges and recent advances
    • Obach RS (2009) Predicting drug-drug interactions from in vitro drug metabolism data: challenges and recent advances. Curr Opin Drug Discov Devel 12:81-89.
    • (2009) Curr Opin Drug Discov Devel , vol.12 , pp. 81-89
    • Obach, R.S.1
  • 136
    • 1842432543 scopus 로고    scopus 로고
    • Biopharmaceutics classification by high throughput solubility assay and PAMPA
    • Obata K, Sugano K, Machida M, and Aso Y (2004) Biopharmaceutics classification by high throughput solubility assay and PAMPA. Drug Dev Ind Pharm 30:181-185.
    • (2004) Drug Dev Ind Pharm , vol.30 , pp. 181-185
    • Obata, K.1    Sugano, K.2    Machida, M.3    Aso, Y.4
  • 137
    • 84455194082 scopus 로고    scopus 로고
    • Simultaneous absolute protein quantification of transporters, cytochromes P450, and UDP-glucuronosyltransferases as a novel approach for the characterization of individual human liver: Comparison with mRNA levels and activities
    • Ohtsuki S, Schaefer O, Kawakami H, Inoue T, Liehner S, Saito A, Ishiguro N, Kishimoto W, Ludwig-Schwellinger E, and Ebner T, et al. (2012) Simultaneous absolute protein quantification of transporters, cytochromes P450, and UDP-glucuronosyltransferases as a novel approach for the characterization of individual human liver: comparison with mRNA levels and activities. Drug Metab Dispos 40:83-92.
    • (2012) Drug Metab Dispos , vol.40 , pp. 83-92
    • Ohtsuki, S.1    Schaefer, O.2    Kawakami, H.3    Inoue, T.4    Liehner, S.5    Saito, A.6    Ishiguro, N.7    Kishimoto, W.8    Ludwig-Schwellinger, E.9    Ebner, T.10
  • 138
    • 0018668570 scopus 로고
    • Effect of altered plasma protein binding on apparent volume of distribution
    • Oie S and Tozer TN (1979) Effect of altered plasma protein binding on apparent volume of distribution. J Pharm Sci 68:1203-1205.
    • (1979) J Pharm Sci , vol.68 , pp. 1203-1205
    • Oie, S.1    Tozer, T.N.2
  • 141
    • 79956123094 scopus 로고    scopus 로고
    • Prediction of human renal clearance from preclinical species for a diverse set of drugs that exhibit both active secretion and net reabsorption
    • Paine SW, Ménochet K, Denton R, McGinnity DF, and Riley RJ (2011) Prediction of human renal clearance from preclinical species for a diverse set of drugs that exhibit both active secretion and net reabsorption. Drug Metab Dispos 39:1008-1013.
    • (2011) Drug Metab Dispos , vol.39 , pp. 1008-1013
    • Paine, S.W.1    Ménochet, K.2    Denton, R.3    McGinnity, D.F.4    Riley, R.J.5
  • 142
    • 0017603437 scopus 로고
    • Hepatic clearance of drugs. I. Theoretical considerations of a "well-stirred" model and a "parallel tube" model. Influence of hepatic blood flow, plasma and blood cell binding, and the hepatocellular enzymatic activity on hepatic drug clearance
    • Pang KS and Rowland M (1977) Hepatic clearance of drugs. I. Theoretical considerations of a "well-stirred" model and a "parallel tube" model. Influence of hepatic blood flow, plasma and blood cell binding, and the hepatocellular enzymatic activity on hepatic drug clearance. J Pharmacokinet Biopharm 5:625-653.
    • (1977) J Pharmacokinet Biopharm , vol.5 , pp. 625-653
    • Pang, K.S.1    Rowland, M.2
  • 143
    • 46449096570 scopus 로고    scopus 로고
    • Rate-limiting steps in hepatic drug clearance: Comparison of hepatocellular uptake and metabolism with microsomal metabolism of saquinavir, nelfinavir, and ritonavir
    • Parker AJ and Houston JB (2008) Rate-limiting steps in hepatic drug clearance: comparison of hepatocellular uptake and metabolism with microsomal metabolism of saquinavir, nelfinavir, and ritonavir. Drug Metab Dispos 36:1375-1384.
    • (2008) Drug Metab Dispos , vol.36 , pp. 1375-1384
    • Parker, A.J.1    Houston, J.B.2
  • 144
    • 84881609631 scopus 로고    scopus 로고
    • Toward a new paradigm for the efficient in vitro-in vivo extrapolation of metabolic clearance in humans from hepatocyte data
    • Poulin P and Haddad S (2013) Toward a new paradigm for the efficient in vitro-in vivo extrapolation of metabolic clearance in humans from hepatocyte data. J Pharm Sci 102:3239-3251.
    • (2013) J Pharm Sci , vol.102 , pp. 3239-3251
    • Poulin, P.1    Haddad, S.2
  • 145
    • 0036144815 scopus 로고    scopus 로고
    • Prediction of pharmacokinetics prior to in vivo studies. 1. Mechanism-based prediction of volume of distribution
    • Poulin P and Theil F-P (2002) Prediction of pharmacokinetics prior to in vivo studies. 1. Mechanism-based prediction of volume of distribution. J Pharm Sci 91:129-156.
    • (2002) J Pharm Sci , vol.91 , pp. 129-156
    • Poulin, P.1    Theil, F.-P.2
  • 146
    • 1542344547 scopus 로고    scopus 로고
    • Predicting drug clearance from recombinantly expressed CYPs: Intersystem extrapolation factors
    • Proctor NJ, Tucker GT, and Rostami-Hodjegan A (2004) Predicting drug clearance from recombinantly expressed CYPs: intersystem extrapolation factors. Xenobiotica 34:151-178.
    • (2004) Xenobiotica , vol.34 , pp. 151-178
    • Proctor, N.J.1    Tucker, G.T.2    Rostami-Hodjegan, A.3
  • 147
    • 0017335453 scopus 로고
    • Prediction of hepatic extraction ratio from in vitro measurement of intrinsic clearance
    • Rane A, Wilkinson GR, and Shand DG (1977) Prediction of hepatic extraction ratio from in vitro measurement of intrinsic clearance. J Pharmacol Exp Ther 200:420-424.
    • (1977) J Pharmacol Exp Ther , vol.200 , pp. 420-424
    • Rane, A.1    Wilkinson, G.R.2    Shand, D.G.3
  • 148
    • 84868204415 scopus 로고    scopus 로고
    • Tissue lipids and drug distribution: Dog versus rat
    • Rodgers T, Jones HM, and Rowland M (2012) Tissue lipids and drug distribution: dog versus rat. J Pharm Sci 101:4615-4626.
    • (2012) J Pharm Sci , vol.101 , pp. 4615-4626
    • Rodgers, T.1    Jones, H.M.2    Rowland, M.3
  • 149
    • 21344469211 scopus 로고    scopus 로고
    • Physiologically based pharmacokinetic modeling 1: Predicting the tissue distribution of moderate-to-strong bases
    • Rodgers T, Leahy D, and Rowland M (2005) Physiologically based pharmacokinetic modeling 1: predicting the tissue distribution of moderate-to-strong bases. J Pharm Sci 94:1259-1276.
    • (2005) J Pharm Sci , vol.94 , pp. 1259-1276
    • Rodgers, T.1    Leahy, D.2    Rowland, M.3
  • 150
    • 33745055239 scopus 로고    scopus 로고
    • Physiologically based pharmacokinetic modelling 2: Predicting the tissue distribution of acids, very weak bases, neutrals and zwitterions
    • Rodgers T and Rowland M (2006) Physiologically based pharmacokinetic modelling 2: predicting the tissue distribution of acids, very weak bases, neutrals and zwitterions. J Pharm Sci 95:1238-1257.
    • (2006) J Pharm Sci , vol.95 , pp. 1238-1257
    • Rodgers, T.1    Rowland, M.2
  • 151
    • 34247556082 scopus 로고    scopus 로고
    • Mechanistic approaches to volume of distribution predictions: Understanding the processes
    • Rodgers T and Rowland M (2007) Mechanistic approaches to volume of distribution predictions: understanding the processes. Pharm Res 24:918-933.
    • (2007) Pharm Res , vol.24 , pp. 918-933
    • Rodgers, T.1    Rowland, M.2
  • 152
    • 84862619047 scopus 로고    scopus 로고
    • Physiologically based pharmacokinetics joined with in vitro-in vivo extrapolation of ADME: A marriage under the arch of systems pharmacology
    • Rostami-Hodjegan A (2012) Physiologically based pharmacokinetics joined with in vitro-in vivo extrapolation of ADME: a marriage under the arch of systems pharmacology. Clin Pharmacol Ther 92:50-61.
    • (2012) Clin Pharmacol Ther , vol.92 , pp. 50-61
    • Rostami-Hodjegan, A.1
  • 153
    • 0036614033 scopus 로고    scopus 로고
    • The effects of portal shunts on intestinal cytochrome P450 3A activity
    • Rostami-Hodjegan A and Tucker GT (2002) The effects of portal shunts on intestinal cytochrome P450 3A activity. Hepatology 35:1549-1550.
    • (2002) Hepatology , vol.35 , pp. 1549-1550
    • Rostami-Hodjegan, A.1    Tucker, G.T.2
  • 157
    • 77549084821 scopus 로고    scopus 로고
    • Physiologically based mechanistic modelling to predict complex drug-drug interactions involving simultaneous competitive and time-dependent enzyme inhibition by parent compound and its metabolite in both liver and gut - The effect of diltiazem on the time-course of exposure to triazolam
    • Rowland Yeo K, Jamei M, Yang J, Tucker GT, and Rostami-Hodjegan A (2010) Physiologically based mechanistic modelling to predict complex drug-drug interactions involving simultaneous competitive and time-dependent enzyme inhibition by parent compound and its metabolite in both liver and gut - the effect of diltiazem on the time-course of exposure to triazolam. Eur J Pharm Sci 39:298-309.
    • (2010) Eur J Pharm Sci , vol.39 , pp. 298-309
    • Rowland Yeo, K.1    Jamei, M.2    Yang, J.3    Tucker, G.T.4    Rostami-Hodjegan, A.5
  • 158
    • 79957493995 scopus 로고    scopus 로고
    • Prediction of time-dependent CYP3A4 drug-drug interactions by physiologically based pharmacokinetic modelling: Impact of inactivation parameters and enzyme turnover
    • Rowland Yeo K, Walsky RL, Jamei M, Rostami-Hodjegan A, and Tucker GT (2011) Prediction of time-dependent CYP3A4 drug-drug interactions by physiologically based pharmacokinetic modelling: impact of inactivation parameters and enzyme turnover. Eur J Pharm Sci 43:160-173.
    • (2011) Eur J Pharm Sci , vol.43 , pp. 160-173
    • Rowland Yeo, K.1    Walsky, R.L.2    Jamei, M.3    Rostami-Hodjegan, A.4    Tucker, G.T.5
  • 159
    • 0035120237 scopus 로고    scopus 로고
    • Determination of the aqueous solubility of drugs using a convenient 96-well plate-based assay
    • Roy D, Ducher F, Laumain A, and Legendre JY (2001) Determination of the aqueous solubility of drugs using a convenient 96-well plate-based assay. Drug Dev Ind Pharm 27:107-109.
    • (2001) Drug Dev Ind Pharm , vol.27 , pp. 107-109
    • Roy, D.1    Ducher, F.2    Laumain, A.3    Legendre, J.Y.4
  • 161
    • 84864287453 scopus 로고    scopus 로고
    • Prediction of the in vivo OATP1B1-mediated drug-drug interaction potential of an investigational drug against a range of statins
    • Sharma P, Butters CJ, Smith V, Elsby R, and Surry D (2012) Prediction of the in vivo OATP1B1-mediated drug-drug interaction potential of an investigational drug against a range of statins. Eur J Pharm Sci 47:244-255.
    • (2012) Eur J Pharm Sci , vol.47 , pp. 244-255
    • Sharma, P.1    Butters, C.J.2    Smith, V.3    Elsby, R.4    Surry, D.5
  • 162
    • 84874437997 scopus 로고    scopus 로고
    • Cynomolgus monkey as a potential model to assess drug interactions involving hepatic organic anion transporting polypeptides (OATPs), in vitro, in vivo and in vitro-to-in vivo extrapolation
    • Shen H, Yang Z, Mintier G, Han Y-H, Chen C, Balimane P, Jemal M, Zhao W, Zhang R, and Kallipatti S, et al. (2013) Cynomolgus monkey as a potential model to assess drug interactions involving hepatic organic anion transporting polypeptides (OATPs), in vitro, in vivo and in vitro-to-in vivo extrapolation. J Pharmacol Exp Ther 344:673-685.
    • (2013) J Pharmacol Exp Ther , vol.344 , pp. 673-685
    • Shen, H.1    Yang, Z.2    Mintier, G.3    Han, Y.-H.4    Chen, C.5    Balimane, P.6    Jemal, M.7    Zhao, W.8    Zhang, R.9    Kallipatti, S.10
  • 163
    • 33644847684 scopus 로고    scopus 로고
    • Transporters as a determinant of drug clearance and tissue distribution
    • Shitara Y, Horie T, and Sugiyama Y (2006) Transporters as a determinant of drug clearance and tissue distribution. Eur J Pharm Sci 27:425-446.
    • (2006) Eur J Pharm Sci , vol.27 , pp. 425-446
    • Shitara, Y.1    Horie, T.2    Sugiyama, Y.3
  • 164
    • 33748042671 scopus 로고    scopus 로고
    • Pharmacokinetic and pharmacodynamic alterations of 3-hydroxy-3- methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors: Drug-drug interactions and interindividual differences in transporter and metabolic enzyme functions
    • Shitara Y and Sugiyama Y (2006) Pharmacokinetic and pharmacodynamic alterations of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors: drug-drug interactions and interindividual differences in transporter and metabolic enzyme functions. Pharmacol Ther 112:71-105.
    • (2006) Pharmacol Ther , vol.112 , pp. 71-105
    • Shitara, Y.1    Sugiyama, Y.2
  • 165
    • 68149170038 scopus 로고    scopus 로고
    • The role of transporters in the pharmacokinetics of orally administered drugs
    • Shugarts S and Benet LZ (2009) The role of transporters in the pharmacokinetics of orally administered drugs. Pharm Res 26:2039-2054.
    • (2009) Pharm Res , vol.26 , pp. 2039-2054
    • Shugarts, S.1    Benet, L.Z.2
  • 167
    • 84858660647 scopus 로고    scopus 로고
    • From preclinical to human - Prediction of oral absorption and drug-drug interaction potential using physiologically based pharmacokinetic (PBPK) modeling approach in an industrial setting: A workflow by using case example
    • Sinha VK, Snoeys J, Osselaer NV, Peer AV, Mackie C, and Heald D (2012) From preclinical to human - prediction of oral absorption and drug-drug interaction potential using physiologically based pharmacokinetic (PBPK) modeling approach in an industrial setting: a workflow by using case example. Biopharm Drug Dispos 33:111-121.
    • (2012) Biopharm Drug Dispos , vol.33 , pp. 111-121
    • Sinha, V.K.1    Snoeys, J.2    Osselaer, N.V.3    Peer, A.V.4    Mackie, C.5    Heald, D.6
  • 168
    • 53849093733 scopus 로고    scopus 로고
    • Current industrial practices in assessing CYP450 enzyme induction: Preclinical and clinical
    • Sinz M, Wallace G, and Sahi J (2008) Current industrial practices in assessing CYP450 enzyme induction: preclinical and clinical. AAPS J 10:391-400.
    • (2008) AAPS J , vol.10 , pp. 391-400
    • Sinz, M.1    Wallace, G.2    Sahi, J.3
  • 169
    • 82955239907 scopus 로고    scopus 로고
    • Pfizer Sandwich Laboratories: Where drug metabolism first met drug discovery
    • Smith D (2012) Pfizer Sandwich Laboratories: where drug metabolism first met drug discovery. Xenobiotica 42:2-3.
    • (2012) Xenobiotica , vol.42 , pp. 2-3
    • Smith, D.1
  • 170
    • 84863893492 scopus 로고    scopus 로고
    • The development, characterization, and application of an OATP1B1 inhibition assay in drug discovery
    • Soars MG, Barton P, Ismair M, Jupp R, and Riley RJ (2012) The development, characterization, and application of an OATP1B1 inhibition assay in drug discovery. Drug Metab Dispos 40: 1641-1648.
    • (2012) Drug Metab Dispos , vol.40 , pp. 1641-1648
    • Soars, M.G.1    Barton, P.2    Ismair, M.3    Jupp, R.4    Riley, R.J.5
  • 171
    • 34249006024 scopus 로고    scopus 로고
    • Use of hepatocytes to assess the contribution of hepatic uptake to clearance in vivo
    • Soars MG, Grime K, Sproston JL, Webborn PJ, and Riley RJ (2007) Use of hepatocytes to assess the contribution of hepatic uptake to clearance in vivo. Drug Metab Dispos 35:859-865.
    • (2007) Drug Metab Dispos , vol.35 , pp. 859-865
    • Soars, M.G.1    Grime, K.2    Sproston, J.L.3    Webborn, P.J.4    Riley, R.J.5
  • 172
    • 71949098636 scopus 로고    scopus 로고
    • Impact of hepatic uptake transporters on pharmacokinetics and drug-drug interactions: Use of assays and models for decision making in the pharmaceutical industry
    • Soars MG, Webborn PJ, and Riley RJ (2009) Impact of hepatic uptake transporters on pharmacokinetics and drug-drug interactions: use of assays and models for decision making in the pharmaceutical industry. Mol Pharm 6:1662-1677.
    • (2009) Mol Pharm , vol.6 , pp. 1662-1677
    • Soars, M.G.1    Webborn, P.J.2    Riley, R.J.3
  • 173
    • 66449122160 scopus 로고    scopus 로고
    • Evaluation of recombinant cytochrome P450 enzymes as an in vitro system for metabolic clearance predictions
    • Stringer RA, Strain-Damerell C, Nicklin P, and Houston JB (2009) Evaluation of recombinant cytochrome P450 enzymes as an in vitro system for metabolic clearance predictions. Drug Metab Dispos 37:1025-1034.
    • (2009) Drug Metab Dispos , vol.37 , pp. 1025-1034
    • Stringer, R.A.1    Strain-Damerell, C.2    Nicklin, P.3    Houston, J.B.4
  • 174
    • 78649637016 scopus 로고    scopus 로고
    • Contribution of molecular properties to extrapolation of the volume of distribution in human from preclinical animal species data
    • Sui X, Sun J, Li H, Pan Y, Wang Y, and He Z (2010) Contribution of molecular properties to extrapolation of the volume of distribution in human from preclinical animal species data. Biopharm Drug Dispos 31:464-475.
    • (2010) Biopharm Drug Dispos , vol.31 , pp. 464-475
    • Sui, X.1    Sun, J.2    Li, H.3    Pan, Y.4    Wang, Y.5    He, Z.6
  • 175
    • 0033256510 scopus 로고    scopus 로고
    • Transporters for bile acids and organic anions
    • Suzuki H and Sugiyama Y (1999) Transporters for bile acids and organic anions. Pharm Biotechnol 12:387-439.
    • (1999) Pharm Biotechnol , vol.12 , pp. 387-439
    • Suzuki, H.1    Sugiyama, Y.2
  • 176
    • 61449118888 scopus 로고    scopus 로고
    • Species differences in blood-brain barrier transport of three positron emission tomography radioligands with emphasis on P-glycoprotein transport
    • Syvänen S, Lindhe O, Palner M, Kornum BR, Rahman O, Långström B, Knudsen GM, and Hammarlund-Udenaes M (2009) Species differences in blood-brain barrier transport of three positron emission tomography radioligands with emphasis on P-glycoprotein transport. Drug Metab Dispos 37:635-643.
    • (2009) Drug Metab Dispos , vol.37 , pp. 635-643
    • Syvänen, S.1    Lindhe, O.2    Palner, M.3    Kornum, B.R.4    Rahman, O.5    Långström, B.6    Knudsen, G.M.7    Hammarlund-Udenaes, M.8
  • 177
    • 79851478871 scopus 로고    scopus 로고
    • Predicting drug-drug interactions involving the inhibition of intestinal CYP3A4 and P-glycoprotein
    • Tachibana T, Kato M, Takano J, and Sugiyama Y (2010) Predicting drug-drug interactions involving the inhibition of intestinal CYP3A4 and P-glycoprotein. Curr Drug Metab 11:762-777.
    • (2010) Curr Drug Metab , vol.11 , pp. 762-777
    • Tachibana, T.1    Kato, M.2    Takano, J.3    Sugiyama, Y.4
  • 178
    • 33644749355 scopus 로고    scopus 로고
    • Is the monkey an appropriate animal model to examine drug-drug interactions involving renal clearance? Effect of probenecid on the renal elimination of H2 receptor antagonists
    • Tahara H, Kusuhara H, Chida M, Fuse E, and Sugiyama Y (2006) Is the monkey an appropriate animal model to examine drug-drug interactions involving renal clearance? Effect of probenecid on the renal elimination of H2 receptor antagonists. J Pharmacol Exp Ther 316:1187-1194.
    • (2006) J Pharmacol Exp Ther , vol.316 , pp. 1187-1194
    • Tahara, H.1    Kusuhara, H.2    Chida, M.3    Fuse, E.4    Sugiyama, Y.5
  • 180
    • 70349645316 scopus 로고    scopus 로고
    • The species differences of intestinal drug absorption and first-pass metabolism between cynomolgus monkeys and humans
    • Takahashi M, Washio T, Suzuki N, Igeta K, and Yamashita S (2009) The species differences of intestinal drug absorption and first-pass metabolism between cynomolgus monkeys and humans. J Pharm Sci 98:4343-4353.
    • (2009) J Pharm Sci , vol.98 , pp. 4343-4353
    • Takahashi, M.1    Washio, T.2    Suzuki, N.3    Igeta, K.4    Yamashita, S.5
  • 181
    • 0037378726 scopus 로고    scopus 로고
    • Segmental intestinal transporters and metabolic enzymes on intestinal drug absorption
    • Tam D, Tirona RG, and Pang KS (2003) Segmental intestinal transporters and metabolic enzymes on intestinal drug absorption. Drug Metab Dispos 31:373-383.
    • (2003) Drug Metab Dispos , vol.31 , pp. 373-383
    • Tam, D.1    Tirona, R.G.2    Pang, K.S.3
  • 182
    • 84859712703 scopus 로고    scopus 로고
    • Oral drug delivery utilizing intestinal OATP transporters
    • Tamai I (2012) Oral drug delivery utilizing intestinal OATP transporters. Adv Drug Deliv Rev 64:508-514.
    • (2012) Adv Drug Deliv Rev , vol.64 , pp. 508-514
    • Tamai, I.1
  • 183
    • 33344457255 scopus 로고    scopus 로고
    • A global examination of allometric scaling for predicting human drug clearance and the prediction of large vertical allometry
    • Tang H and Mayersohn M (2006) A global examination of allometric scaling for predicting human drug clearance and the prediction of large vertical allometry. J Pharm Sci 95:1783-1799.
    • (2006) J Pharm Sci , vol.95 , pp. 1783-1799
    • Tang, H.1    Mayersohn, M.2
  • 184
    • 36048955673 scopus 로고    scopus 로고
    • Gut instincts: CYP3A4 and intestinal drug metabolism
    • Thummel KE (2007) Gut instincts: CYP3A4 and intestinal drug metabolism. J Clin Invest 117:3173-3176.
    • (2007) J Clin Invest , vol.117 , pp. 3173-3176
    • Thummel, K.E.1
  • 185
    • 84860858293 scopus 로고    scopus 로고
    • Novel in vitro-in vivo extrapolation (IVIVE) method to predict hepatic organ clearance in rat
    • Umehara K and Camenisch G (2012) Novel in vitro-in vivo extrapolation (IVIVE) method to predict hepatic organ clearance in rat. Pharm Res 29:603-617.
    • (2012) Pharm Res , vol.29 , pp. 603-617
    • Umehara, K.1    Camenisch, G.2
  • 186
    • 79251578340 scopus 로고    scopus 로고
    • Estimating unbound volume of distribution and tissue binding by in vitro HPLC-based human serum albumin and immobilised artificial membrane-binding measurements
    • Valkó KL, Nunhuck SB, and Hill AP (2011) Estimating unbound volume of distribution and tissue binding by in vitro HPLC-based human serum albumin and immobilised artificial membrane-binding measurements. J Pharm Sci 100:849-862.
    • (2011) J Pharm Sci , vol.100 , pp. 849-862
    • Valkó, K.L.1    Nunhuck, S.B.2    Hill, A.P.3
  • 188
    • 84863894140 scopus 로고    scopus 로고
    • Physicochemical property space of hepatobiliary transport and computational models for predicting rat biliary excretion
    • Varma MV, Chang G, Lai Y, Feng B, El-Kattan AF, Litchfield J, and Goosen TC (2012a) Physicochemical property space of hepatobiliary transport and computational models for predicting rat biliary excretion. Drug Metab Dispos 40:1527-1537.
    • (2012) Drug Metab Dispos , vol.40 , pp. 1527-1537
    • Varma, M.V.1    Chang, G.2    Lai, Y.3    Feng, B.4    El-Kattan, A.F.5    Litchfield, J.6    Goosen, T.C.7
  • 189
    • 84860755198 scopus 로고    scopus 로고
    • pH-Dependent solubility and permeability criteria for provisional biopharmaceutics classification (BCS and BDDCS) in early drug discovery
    • Varma MV, Gardner I, Steyn SJ, Nkansah P, Rotter CJ, Whitney-Pickett C, Zhang H, Di L, Cram M, and Fenner KS, et al. (2012b) pH-Dependent solubility and permeability criteria for provisional biopharmaceutics classification (BCS and BDDCS) in early drug discovery. Mol Pharm 9:1199-1212.
    • (2012) Mol Pharm , vol.9 , pp. 1199-1212
    • Varma, M.V.1    Gardner, I.2    Steyn, S.J.3    Nkansah, P.4    Rotter, C.J.5    Whitney-Pickett, C.6    Zhang, H.7    Cram M, D.L.8    Fenner, K.S.9
  • 191
    • 84866708911 scopus 로고    scopus 로고
    • Physiologically based modeling of pravastatin transporter-mediated hepatobiliary disposition and drug-drug interactions
    • Varma MV, Lai Y, Feng B, Litchfield J, Goosen TC, and Bergman A (2012c) Physiologically based modeling of pravastatin transporter-mediated hepatobiliary disposition and drug-drug interactions. Pharm Res 29:2860-2873.
    • (2012) Pharm Res , vol.29 , pp. 2860-2873
    • Varma, M.V.1    Lai, Y.2    Feng, B.3    Litchfield, J.4    Goosen, T.C.5    Bergman, A.6
  • 192
    • 84877786965 scopus 로고    scopus 로고
    • Response to the comment on the article "physiologically based modeling of pravastatin transporter-mediated hepatobiliary disposition and drug-drug interactions"
    • Varma MV, Lai Y, Feng B, Litchfield J, Goosen TC, and Bergman A (2013a) Response to the comment on the article "physiologically based modeling of pravastatin transporter-mediated hepatobiliary disposition and drug-drug interactions". Pharm Res 30:1469-1470.
    • (2013) Pharm Res , vol.30 , pp. 1469-1470
    • Varma, M.V.1    Lai, Y.2    Feng, B.3    Litchfield, J.4    Goosen, T.C.5    Bergman, A.6
  • 193
    • 84876483882 scopus 로고    scopus 로고
    • Mechanistic modeling to predict the transporter- and enzyme-mediated drug-drug interactions of repaglinide
    • Varma MV, Lai Y, Kimoto E, Goosen TC, El-Kattan AF, and Kumar V (2013b) Mechanistic modeling to predict the transporter- and enzyme-mediated drug-drug interactions of repaglinide. Pharm Res 30:1188-1199.
    • (2013) Pharm Res , vol.30 , pp. 1188-1199
    • Varma, M.V.1    Lai, Y.2    Kimoto, E.3    Goosen, T.C.4    El-Kattan, A.F.5    Kumar, V.6
  • 194
    • 84876752739 scopus 로고    scopus 로고
    • Quantitative prediction of repaglinide-rifampicin complex drug interactions using dynamic and static mechanistic models: Delineating differential CYP3A4 induction and OATP1B1 inhibition potential of rifampicin
    • Varma MV, Lin J, Bi YA, Rotter CJ, Fahmi OA, Lam JL, El-Kattan AF, Goosen TC, and Lai Y (2013c) Quantitative prediction of repaglinide-rifampicin complex drug interactions using dynamic and static mechanistic models: delineating differential CYP3A4 induction and OATP1B1 inhibition potential of rifampicin. Drug Metab Dispos 41:966-974.
    • (2013) Drug Metab Dispos , vol.41 , pp. 966-974
    • Varma, M.V.1    Lin, J.2    Bi, Y.A.3    Rotter, C.J.4    Fahmi, O.A.5    Lam, J.L.6    El-Kattan, A.F.7    Goosen, T.C.8    Lai, Y.9
  • 195
    • 77249122159 scopus 로고    scopus 로고
    • Physicochemical space for optimum oral bioavailability: Contribution of human intestinal absorption and first-pass elimination
    • Varma MV, Obach RS, Rotter C, Miller HR, Chang G, Steyn SJ, El-Kattan A, and Troutman MD (2010) Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination. J Med Chem 53:1098-1108.
    • (2010) J Med Chem , vol.53 , pp. 1098-1108
    • Varma, M.V.1    Obach, R.S.2    Rotter, C.3    Miller, H.R.4    Chang, G.5    Steyn, S.J.6    El-Kattan, A.7    Troutman, M.D.8
  • 196
    • 20744446221 scopus 로고    scopus 로고
    • Prediction of in vivo intestinal absorption enhancement on P-glycoprotein inhibition, from rat in situ permeability
    • Varma MV and Panchagnula R (2005) Prediction of in vivo intestinal absorption enhancement on P-glycoprotein inhibition, from rat in situ permeability. J Pharm Sci 94:1694-1704.
    • (2005) J Pharm Sci , vol.94 , pp. 1694-1704
    • Varma, M.V.1    Panchagnula, R.2
  • 198
    • 0033674502 scopus 로고    scopus 로고
    • Comparison between cytochrome P450 (CYP) content and relative activity approaches to scaling from cDNA-expressed CYPs to human liver microsomes: Ratios of accessory proteins as sources of discrepancies between the approaches
    • Venkatakrishnan K, von Moltke LL, Court MH, Harmatz JS, Crespi CL, and Greenblatt DJ (2000) Comparison between cytochrome P450 (CYP) content and relative activity approaches to scaling from cDNA-expressed CYPs to human liver microsomes: ratios of accessory proteins as sources of discrepancies between the approaches. Drug Metab Dispos 28:1493-1504.
    • (2000) Drug Metab Dispos , vol.28 , pp. 1493-1504
    • Venkatakrishnan, K.1    Von Moltke, L.L.2    Court, M.H.3    Harmatz, J.S.4    Crespi, C.L.5    Greenblatt, D.J.6
  • 199
    • 1542376174 scopus 로고    scopus 로고
    • Cytochrome P450 3A4 and P-glycoprotein expression in human small intestinal enterocytes and hepatocytes: A comparative analysis in paired tissue specimens
    • von Richter O, Burk O, Fromm MF, Thon KP, Eichelbaum M, and Kivistö KT (2004) Cytochrome P450 3A4 and P-glycoprotein expression in human small intestinal enterocytes and hepatocytes: a comparative analysis in paired tissue specimens. Clin Pharmacol Ther 75:172-183.
    • (2004) Clin Pharmacol Ther , vol.75 , pp. 172-183
    • Von Richter, O.1    Burk, O.2    Fromm, M.F.3    Thon, K.P.4    Eichelbaum, M.5    Kivistö, K.T.6
  • 200
    • 0035290059 scopus 로고    scopus 로고
    • Active secretion and enterocytic drug metabolism barriers to drug absorption
    • Wacher VJ, Salphati L, and Benet LZ (2001) Active secretion and enterocytic drug metabolism barriers to drug absorption. Adv Drug Deliv Rev 46:89-102.
    • (2001) Adv Drug Deliv Rev , vol.46 , pp. 89-102
    • Wacher, V.J.1    Salphati, L.2    Benet, L.Z.3
  • 201
    • 3042648079 scopus 로고    scopus 로고
    • Prediction of human pharmacokinetic profile in animal scale up based on normalizing time course profiles
    • Wajima T, Yano Y, Fukumura K, and Oguma T (2004) Prediction of human pharmacokinetic profile in animal scale up based on normalizing time course profiles. J Pharm Sci 93:1890-1900.
    • (2004) J Pharm Sci , vol.93 , pp. 1890-1900
    • Wajima, T.1    Yano, Y.2    Fukumura, K.3    Oguma, T.4
  • 202
    • 79951931440 scopus 로고    scopus 로고
    • Validation of isolated metabolites from drug metabolism studies as analytical standards by quantitative NMR
    • Walker GS, Ryder TF, Sharma R, Smith EB, and Freund A (2011) Validation of isolated metabolites from drug metabolism studies as analytical standards by quantitative NMR. Drug Metab Dispos 39:433-440.
    • (2011) Drug Metab Dispos , vol.39 , pp. 433-440
    • Walker, G.S.1    Ryder, T.F.2    Sharma, R.3    Smith, E.B.4    Freund, A.5
  • 203
    • 77953787344 scopus 로고    scopus 로고
    • Confidence assessment of the Simcyp time-based approach and a static mathematical model in predicting clinical drug-drug interactions for mechanism-based CYP3A inhibitors
    • Wang YH (2010) Confidence assessment of the Simcyp time-based approach and a static mathematical model in predicting clinical drug-drug interactions for mechanism-based CYP3A inhibitors. Drug Metab Dispos 38:1094-1104.
    • (2010) Drug Metab Dispos , vol.38 , pp. 1094-1104
    • Wang, Y.H.1
  • 204
    • 2442691625 scopus 로고    scopus 로고
    • A comprehensive quantitative and qualitative evaluation of extrapolation of intravenous pharmacokinetic parameters from rat, dog, and monkey to humans. II. Volume of distribution and mean residence time
    • Ward KW and Smith BR (2004) A comprehensive quantitative and qualitative evaluation of extrapolation of intravenous pharmacokinetic parameters from rat, dog, and monkey to humans. II. Volume of distribution and mean residence time. Drug Metab Dispos 32:612-619.
    • (2004) Drug Metab Dispos , vol.32 , pp. 612-619
    • Ward, K.W.1    Smith, B.R.2
  • 205
    • 59649130318 scopus 로고    scopus 로고
    • Physiologically based pharmacokinetic modeling to predict transporter-mediated clearance and distribution of pravastatin in humans
    • Watanabe T, Kusuhara H, Maeda K, Shitara Y, and Sugiyama Y (2009a) Physiologically based pharmacokinetic modeling to predict transporter-mediated clearance and distribution of pravastatin in humans. J Pharmacol Exp Ther 328:652-662.
    • (2009) J Pharmacol Exp Ther , vol.328 , pp. 652-662
    • Watanabe, T.1    Kusuhara, H.2    Maeda, K.3    Shitara, Y.4    Sugiyama, Y.5
  • 206
    • 79951768576 scopus 로고    scopus 로고
    • Application of physiologically based pharmacokinetic modeling and clearance concept to drugs showing transporter-mediated distribution and clearance in humans
    • Watanabe T, Kusuhara H, and Sugiyama Y (2010) Application of physiologically based pharmacokinetic modeling and clearance concept to drugs showing transporter-mediated distribution and clearance in humans. J Pharmacokinet Pharmacodyn 37:575-590.
    • (2010) J Pharmacokinet Pharmacodyn , vol.37 , pp. 575-590
    • Watanabe, T.1    Kusuhara, H.2    Sugiyama, Y.3
  • 207
    • 67649406103 scopus 로고    scopus 로고
    • Prediction of the hepatic and renal clearance of transporter substrates in rats using in vitro uptake experiments
    • Watanabe T, Maeda K, Kondo T, Nakayama H, Horita S, Kusuhara H, and Sugiyama Y (2009b) Prediction of the hepatic and renal clearance of transporter substrates in rats using in vitro uptake experiments. Drug Metab Dispos 37:1471-1479.
    • (2009) Drug Metab Dispos , vol.37 , pp. 1471-1479
    • Watanabe, T.1    Maeda, K.2    Kondo, T.3    Nakayama, H.4    Horita, S.5    Kusuhara, H.6    Sugiyama, Y.7
  • 208
    • 77953777481 scopus 로고    scopus 로고
    • Use of the Øie-Tozer model in understanding mechanisms and determinants of drug distribution
    • Waters NJ and Lombardo F (2010) Use of the Øie-Tozer model in understanding mechanisms and determinants of drug distribution. Drug Metab Dispos 38:1159-1165.
    • (2010) Drug Metab Dispos , vol.38 , pp. 1159-1165
    • Waters, N.J.1    Lombardo, F.2
  • 209
    • 35648929358 scopus 로고    scopus 로고
    • In vitro-in vivo extrapolation of hepatic clearance involving active uptake: Theoretical and experimental aspects
    • Webborn PJ, Parker AJ, Denton RL, and Riley RJ (2007) In vitro-in vivo extrapolation of hepatic clearance involving active uptake: theoretical and experimental aspects. Xenobiotica 37:1090-1109.
    • (2007) Xenobiotica , vol.37 , pp. 1090-1109
    • Webborn, P.J.1    Parker, A.J.2    Denton, R.L.3    Riley, R.J.4
  • 210
    • 0016566218 scopus 로고
    • Commentary: A physiological approach to hepatic drug clearance
    • Wilkinson GR and Shand DG (1975) Commentary: a physiological approach to hepatic drug clearance. Clin Pharmacol Ther 18:377-390.
    • (1975) Clin Pharmacol Ther , vol.18 , pp. 377-390
    • Wilkinson, G.R.1    Shand, D.G.2
  • 211
    • 6944221357 scopus 로고    scopus 로고
    • Drug-drug interactions for UDP-glucuronosyltransferase substrates: A pharmacokinetic explanation for typically observed low exposure (AUCi/AUC) ratios
    • Williams JA, Hyland R, Jones BC, Smith DA, Hurst S, Goosen TC, Peterkin V, Koup JR, and Ball SE (2004) Drug-drug interactions for UDP- glucuronosyltransferase substrates: a pharmacokinetic explanation for typically observed low exposure (AUCi/AUC) ratios. Drug Metab Dispos 32:1201-1208.
    • (2004) Drug Metab Dispos , vol.32 , pp. 1201-1208
    • Williams, J.A.1    Hyland, R.2    Jones, B.C.3    Smith, D.A.4    Hurst, S.5    Goosen, T.C.6    Peterkin, V.7    Koup, J.R.8    Ball, S.E.9
  • 212
    • 17644380257 scopus 로고    scopus 로고
    • Predicting drug disposition via application of BCS: Transport/ absorption/ elimination interplay and development of a biopharmaceutics drug disposition classification system
    • Wu CY and Benet LZ (2005) Predicting drug disposition via application of BCS: transport/ absorption/ elimination interplay and development of a biopharmaceutics drug disposition classification system. Pharm Res 22:11-23.
    • (2005) Pharm Res , vol.22 , pp. 11-23
    • Wu, C.Y.1    Benet, L.Z.2
  • 213
    • 80053161024 scopus 로고    scopus 로고
    • Kinetic characterization of rat hepatic uptake of 16 actively transported drugs
    • Yabe Y, Galetin A, and Houston JB (2011) Kinetic characterization of rat hepatic uptake of 16 actively transported drugs. Drug Metab Dispos 39:1808-1814.
    • (2011) Drug Metab Dispos , vol.39 , pp. 1808-1814
    • Yabe, Y.1    Galetin, A.2    Houston, J.B.3
  • 214
    • 0029782268 scopus 로고    scopus 로고
    • Primary active transport of pravastatin across the liver canalicular membrane in normal and mutant Eisai hyperbilirubinemic rats
    • Yamazaki M, Kobayashi K, and Sugiyama Y (1996) Primary active transport of pravastatin across the liver canalicular membrane in normal and mutant Eisai hyperbilirubinemic rats. Biopharm Drug Dispos 17:607-621.
    • (1996) Biopharm Drug Dispos , vol.17 , pp. 607-621
    • Yamazaki, M.1    Kobayashi, K.2    Sugiyama, Y.3
  • 216
    • 34249274907 scopus 로고    scopus 로고
    • Theoretical assessment of a new experimental protocol for determining kinetic values describing mechanism (time)-based enzyme inhibition
    • Yang J, Jamei M, Yeo KR, Tucker GT, and Rostami-Hodjegan A (2007b) Theoretical assessment of a new experimental protocol for determining kinetic values describing mechanism (time)-based enzyme inhibition. Eur J Pharm Sci 31:232-241.
    • (2007) Eur J Pharm Sci , vol.31 , pp. 232-241
    • Yang, J.1    Jamei, M.2    Yeo, K.R.3    Tucker, G.T.4    Rostami-Hodjegan, A.5
  • 217
    • 24644441043 scopus 로고    scopus 로고
    • Kinetic values for mechanism-based enzyme inhibition: Assessing the bias introduced by the conventional experimental protocol
    • Yang J, Jamei M, Yeo KR, Tucker GT, and Rostami-Hodjegan A (2005) Kinetic values for mechanism-based enzyme inhibition: assessing the bias introduced by the conventional experimental protocol. Eur J Pharm Sci 26:334-340.
    • (2005) Eur J Pharm Sci , vol.26 , pp. 334-340
    • Yang, J.1    Jamei, M.2    Yeo, K.R.3    Tucker, G.T.4    Rostami-Hodjegan, A.5
  • 218
    • 73349114878 scopus 로고    scopus 로고
    • Prediction of biliary excretion in rats and humans using molecular weight and quantitative structure-pharmacokinetic relationships
    • Yang X, Gandhi YA, Duignan DB, and Morris ME (2009) Prediction of biliary excretion in rats and humans using molecular weight and quantitative structure-pharmacokinetic relationships. AAPS J 11:511-525.
    • (2009) AAPS J , vol.11 , pp. 511-525
    • Yang, X.1    Gandhi, Y.A.2    Duignan, D.B.3    Morris, M.E.4
  • 219
    • 84869108969 scopus 로고    scopus 로고
    • Statistical methods for analysis of time-dependent inhibition of cytochrome p450 enzymes
    • Yates P, Eng H, Di L, and Obach RS (2012) Statistical methods for analysis of time-dependent inhibition of cytochrome p450 enzymes. Drug Metab Dispos 40:2289-2296.
    • (2012) Drug Metab Dispos , vol.40 , pp. 2289-2296
    • Yates, P.1    Eng, H.2    Di, L.3    Obach, R.S.4
  • 220
    • 84861349018 scopus 로고    scopus 로고
    • Transporter-mediated drug - Drug interactions involving OATP substrates: Predictions based on in vitro inhibition studies
    • Yoshida K, Maeda K, and Sugiyama Y (2012) Transporter-mediated drug - drug interactions involving OATP substrates: predictions based on in vitro inhibition studies. Clin Pharmacol Ther 91:1053-1064.
    • (2012) Clin Pharmacol Ther , vol.91 , pp. 1053-1064
    • Yoshida, K.1    Maeda, K.2    Sugiyama, Y.3
  • 221
    • 0032888376 scopus 로고    scopus 로고
    • A compartmental absorption and transit model for estimating oral drug absorption
    • Yu LX and Amidon GL (1999) A compartmental absorption and transit model for estimating oral drug absorption. Int J Pharm 186:119-125.
    • (1999) Int J Pharm , vol.186 , pp. 119-125
    • Yu, L.X.1    Amidon, G.L.2
  • 224
    • 84862634533 scopus 로고    scopus 로고
    • Best practice in the use of physiologically based pharmacokinetic modeling and simulation to address clinical pharmacology regulatory questions
    • Zhao P, Rowland M, and Huang SM (2012) Best practice in the use of physiologically based pharmacokinetic modeling and simulation to address clinical pharmacology regulatory questions. Clin Pharmacol Ther 92:17-20.
    • (2012) Clin Pharmacol Ther , vol.92 , pp. 17-20
    • Zhao, P.1    Rowland, M.2    Huang, S.M.3
  • 226
    • 77954897164 scopus 로고    scopus 로고
    • In vitro-in vivo correlation for intrinsic clearance for drugs metabolized by human aldehyde oxidase
    • Zientek M, Jiang Y, Youdim K, and Obach RS (2010) In vitro-in vivo correlation for intrinsic clearance for drugs metabolized by human aldehyde oxidase. Drug Metab Dispos 38:1322-1327.
    • (2010) Drug Metab Dispos , vol.38 , pp. 1322-1327
    • Zientek, M.1    Jiang, Y.2    Youdim, K.3    Obach, R.S.4
  • 227
    • 84860138724 scopus 로고    scopus 로고
    • Prediction of volume of distribution at steady state in humans: Comparison of different approaches
    • Zou P, Zheng N, Yang Y, Yu LX, and Sun D (2012) Prediction of volume of distribution at steady state in humans: comparison of different approaches. Expert Opin Drug Metab Toxicol 8:855-872.
    • (2012) Expert Opin Drug Metab Toxicol , vol.8 , pp. 855-872
    • Zou, P.1    Zheng, N.2    Yang, Y.3    Yu, L.X.4    Sun, D.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.